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Riassunto
La coltura di cellule di mammifero rappresenta il sistema maggiormente utilizzato
per la produzione di proteine terapeutiche a livello industriale. I terreni di coltura
impiegati a tale scopo sono, nella maggior parte dei casi, chimicamente definiti e
specificamente ottimizzati per evitare la penuria di principi nutritivi essenziali per
la produzione. Le cellule mantenute in queste condizioni di coltura, però, possono
presentare un metabolismo alterato, in cui i substrati vengono ossidati in modo in-
completo causando l’accumulo di prodotti secondari. Tra questi vi è l’acido lattico,
che può avere effetti negativi sulla coltura dovuti all’acidificazione del terreno.
Il lattato è normalmente prodotto durante la fase di crescita esponenziale delle
cellule, mentre il suo consumo può avvenire al passaggio alla fase stazionaria. Questo
cambiamento nel metabolismo del lattato non è però comune a tutte le colture in-
dustriali, e nè può essere facilmente controllato, poiché i meccanismi responsabili di
tale fenomeno non sono ancora completamenti definiti.
L’obiettivo principale di questo progetto di tesi è lo studio del metabolismo del
lattato in coltura di cellule CHO, allo scopo di individuare alcuni dei fattori principali
che lo regolano. In particolare, è stato analizzato il ruolo del mitocondrio in questo
fenomeno. A tal scopo sono state impiegate come modello delle linee cellulari carat-
terizzate da opposti profili metabolici del lattato. La fase iniziale di produzione del
lattato è stata associata a una rapida consumazione della glutammina in tutte le col-
ture caratterizzate da una rapida crescita cellulare. In seguito all’esaurimento della
glutammina, sono stati osservati due scenari differenti. In un primo caso, le cellule
consumano il lattato, che quindi diventa una risorsa di energia. Alternativamente, il
lattato continua a essere accumulato nel terreno di coltura, causando una riduzione
del piruvato che viene completamente ossidato a CO2. Pertanto, si è ipotizzato che la
capicità ossidativa del mitocondrio sia una possibile causa dell’eccessivo accumulo
di lattato. Per verificare questa teoria, sono stati misurati il potenziale di membrana
del mitocondrio e il consumo di ossigeno, evidenziando così una interessante corre-
lazione tra il ridotto metabolismo ossidativo e l’elevata produzione di lattato.
Successivamente, è stata anche valutata l’espressione di geni, specificamente se-
lezionati, in correlazione con il metabolismo del lattato. Una riduzione di espres-
sione significativa (|FC≥2|) è stata riscontrata in due geni: precisamente, il trasporta-
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4tore mitocondriale dell’aspartato-glutammato (anche noto come aralar1) e il translo-
catore della membrana interna del mitocondrio, timm8a. Aralar1 è di particolare in-
teresse poichè è un componente della navetta del malato-aspartato. Questa navetta
favorisce l’ossidazione del NADH citosolico, necessaria per evitare un rallentamento
del flusso glicolitico. La sua attività riduce pertanto la quantità di NADH che è invece
utilizzata nella conversione del piruvato a lattato ad opera della lattato deidrogenasi.
Sulla base di questi dati, sono state generate linee cellulari che overesprimono ar-
alar1 o timm8a. Entrambi i geni hanno favorito il passaggio alla fase di consumazione
del lattato nella linea cellulare che normalmente accumulava elevate concentrazioni
di questo metabolita. Invece, quando i due geni sono stati overespressi nella linea
cellulare che già consumava il lattato, nessun cambiamento metabolico è stato os-
servato.
I risultati presentati in questa tesi mostrano che il metabolismo mitocondriale
svolge un ruolo fondamentale nel controllo della produzione del lattato. Inoltre, sia i
terreni di coltura utilizzati che le caratteristiche intrinseche della linea cellulare pos-
sono influenzare l’attività mitocondriale. L’espressione di geni specifici può anche
essere modulata dal terreno di coltura. In particolare, è stata analizzata l’espressione
di aralar1 and timm8a, che vengono proposti come geni promettenti per creare una
linea cellulare ad utilizzo industriale, con un migliore metabolismo del lattato.
Parole chiave: cellule CHO, lattato, glutamminolisi, potenziale di membrana del
mitocondrio, metabolismo ossidativo, aralar, timm8a, navetta malato aspartato, in-
gegnerizzazione cellulare.
Abstract
Mammalian cells represent the most widely used host system for the industrial pro-
duction of recombinant therapeutic proteins. In order to increase productivity, chem-
ically defined media are often used and optimized to provide the cells with the nec-
essary nutrients. However, a deregulated cell metabolism is often observed in these
culture conditions. In particular, carbon sources are fast and inefficiently consumed
with a consequent accumulation of byproducts, mainly lactate and ammonia.
Lactate, in particular, causes a decrease of the medium pH which can be detri-
mental for cells growth and productivity. Its metabolic profile is normally character-
ized by a first production phase, which is associated to the cells exponential growth.
Afterwards, when the cells enter into the stationary phase, a shift to net lactate con-
sumption can occur under optimal culture conditions. However, such a metabolic
shift is not easily controlled, since the mechanisms modulating lactate production in
cell culture are still under investigation.
This work aims to understand which factors could influence the lactate metabolic
shift in CHO cell culture, focusing, in particular, on the mitochondrial role. To this
purpose, cell lines with opposite lactate profiles were compared. The initial lactate
production phase was common to all the fast growing cultures and was concomitant
to a rapid glutamine consumption. After glutamine depletion, two different scenario
occurred. In one case, the cells started to consume lactate until complete deple-
tion. Alternatively, lactate continued to be accumulated, causing a decrease of me-
dia pH. The mitochondrial oxidative capacity was hypothesized as a possible cause of
the different lactate profile. Indeed, mitochondrial membrane potential and oxygen
consumption measurements highlighted a correlation between a reduced oxidative
metabolism and a state of high lactate production. This correlation was confirmed
by evaluating other cell lines or media compositions which resulted in the same di-
vergence of lactate metabolism.
Afterwards, the expression of selected genes was analysed in correlation with
the observed lactate profile. Among 22 genes, two were identified as significantly
downregulated (absolute fold change≥2) in conditions of high lactate accumulation;
namely, the mitochondrial aspartate-glutamate carrier (aralar1) and the translocase
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6of the inner mitochondrial membrane 8 (timm8a). Aralar1, in particular, is an impor-
tant component of the malate-aspartate shuttle (MAS). This system promotes the re-
cycling of the cytosolic NADH pool, which is necessary for maintaining the glycolytic
flux. Alternatively, NADH can be oxidised through pyruvate conversion into lactate,
catalysed by the lactate dehydrogenase enzyme. Therefore, an inefficient MAS activ-
ity can engender an increased lactate accumulation.
Finally, stable cell lines, which overexpressed aralar1 or timm8a, were generated.
Clones derived from a lactate-producing cell line showed an improvement of lactate
metabolism. In particular, they switched more easily to lactate consumption com-
pared to the untransfected control, while maintaining a similar glucose consumption
rate. On the other hand, no impact of the transgene expression was observed in the
clones derived from the lactate-consuming cell line, since the switch to lactate con-
sumption was maintained and no other effect on cell growth or glucose metabolism
was detected. The data obtained indicate that lactate consumption was most likely
promoted by a better NADH oxidation through the malate-aspartate shuttle, which
resulted in a more efficient link between glycolysis and the mitochondrial oxidative
metabolism.
In conclusion, the results presented in this thesis indicate that the mitochondrial
oxidative capacity plays a central role in the control of lactate production. Media
composition and intrinsic cell characteristics have both an impact on mitochondrial
activity. Moreover, the expression of specific genes can also be influenced by the
culture media. In particular, aralar1 and timm8a have been identified as promising
targets for the generation of a host cell line with an improved lactate metabolism.
Keywords: CHO cells, lactate, metabolic shift, glutaminolysis, mitochondrial mem-
brane potential, oxidative metabolism, oxygen consumption, aralar, timm8a, malate
aspartate shuttle, cell engineering
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1Mammalian cell culture in industrial
process
Mammalian cell culture has become the main system for the industrial production
of recombinant therapeutic proteins. Indeed, the complex post-translational modifi-
cations required to obtain highly effective biopharmaceuticals promoted the switch
from bacteria to mammalian cells. Typically used cell lines are chinese hamster ovary
cells (CHO), myeloma cell lines (such as NS0 and Sp2/0), baby hamster kidney (BHK)
and human embryo kidney (HEK-293) cells, (Wurm, 2004). However, CHO cells rep-
resent the host of choice with more than 70 % of commercialized biopharmaceuticals
produced within this cell line (Walsh, 2010). Tissue-type plasminogen activator (tPA)
was the first FDA approved therapeutic protein produced using a mammalian cell
line, precisely CHO cells, in 1987 by Genentech (Ezzell, 1987). The preference for this
cell line is mainly due to its safeness, since it does not propagate human viruses, the
relatively easy transfer of genes into its genome, its robust and fast growth in indus-
trial culture systems and its ability to produce human-like glycoforms. Furthermore,
CHO cells have also acquired a long history of regulatory approval, which is a major
advantage too (Hammond et al., 2011).
CHO cells were originally isolated by Puck et al. in 1958 as fibroblast-like cells
from the ovary of a Chinese hamster (Puck et al., 1958). From this ancestor other cell
lines were generated and adapted to grow in suspension culture. The CHO-K1 cells,
as an example, were derived from a subcloning process of the parental CHO cell (Kao
and Puck, 1968) and afterwards they were mutagenized to generate the CHO-DXB11
cell line, which presents a deletion of one dihydrofolate reductase (dhfr) allele and an
inactivating mutation of the other (Urlaub and Chasin, 1980). Subsequently another
dhfr mutant, named DG44, was obtained from a CHO-pro3− strain (proline depen-
dant) and it lacks both dihydrofolate reductase alleles (Urlaub et al., 1983). CHO-
DXB11 and DG44 represent probably the most widely used CHO-derived host cell
19
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lines. They are both auxotrophic for glycine, hypoxanthine and thymidine, which
are therefore supplemented into the culture media. This characteristic is largely ex-
ploited as a selection method to generate stable clones transfected with both the dhfr
gene and the gene of interest. Moreover, the availability of dhfr inhibitors, such as
methotrexate (MTX), improves the stringency of selection and promotes the trans-
gene amplification.
Another selection strategy is based on the expression of the glutamine synthetase
(GS) gene, even though CHO cells express endogenously this gene. Transgene in-
tegration and amplification are promoted using the inhibitor methionine sulphox-
imine (MSX). This approach has also the advantage of avoiding glutamine addition
to the medium, hence reducing ammonia accumulation (Seth et al., 2006).
Recently, the CHO-K1 genome has been sequenced (Xu et al., 2011), thus opening
new opportunities to better characterize this cell line and to improve its performance
in industrial cell culture by targeting specific genes. However, karyotype studies have
highlighted a considerable genomic heterogeneity between the different CHO cell
lines and especially after recombinant cells generation (Derouazi et al., 2006). This
behaviour complicates industry’s efforts of developing a general and standardized
platform for the production of recombinant proteins in CHO cells.
Nevertheless, resources are constantly dedicated to the pursuit of a better un-
derstanding of CHO cells physiology in industrial bioprocesses. Indeed, since the
first FDA approved drug produced in CHO cells using stirred bioreactors, a strong
improvement has been done in upstream process, leading to an increase in pro-
tein yields to grams/litre range (Walsh, 2010). Main used approaches include cell
line engineering to increase productivity, but also to extend culture longevity; media
and feed optimization, to avoid the negative impact of limiting components or waste
products accumulation on cell growth; and process control (Jain and Kumar, 2008).
In particular the analysis of CHO cells metabolism has gained a strong interest
in the past decades as a tool to improve cell growth and reduce byproducts by tai-
lored media and feed design (Ma et al., 2009). The benefit is an increase in culture
productivity and process robustness (Jain and Kumar, 2008; Mulukutla et al., 2010).
2In vitro metabolism
Industrial cell cultures are often optimized to maintain high viability for extended
period of time in order to increase product yield. Therefore, serum-free media and
complex feeds are designed with the aim of avoiding nutrient limitations and sustain
a rapid cell proliferation. However, they can often become too rich in glucose and
amino acids, which can promote a deregulated metabolisms with a fast and ineffi-
cient consumption of carbon sources. The main drawback is a strong accumulation
of lactate and ammonia, which has a detrimental impact on cell growth and produc-
tivity (Gòdia and Cairó, 2006; Xing et al., 2008). Indeed, a survey of several manufac-
turing runs at Genentech Inc. clearly highlighted a correlation between low lactate
accumulation and optimal productivity (Mulukutla et al., 2012).
Figure 2.1: An optimal lactate profile is characterized by a shift to consumption late
in culture. This improves culture pH as well. From Li et al. (2006)
The major issue of lactate accumulation is the acidification of the medium. In pH
controlled bioreactors this problem is normally addressed by base addition, hence
inducing an increase in osmolarity that is also negative for cell viability. In optimal
conditions, a metabolic switch to lactic acid consumption occurs late in culture (Fig-
21
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ure 2.1).
However, this shift is neither generic nor it can be easily controlled, since the
mechanisms underling it are still under investigations. Several approaches have been
proposed to tackle this phenomenon and will be presented later (see sections 3.1 and
3.2).
The two main metabolic pathways which can lead to high lactate accumulation
are glycolysis and glutaminolysis.
2.1 Glucose metabolism
Glucose is a primary source of energy and intermediates for cell culture. It enters into
two metabolic pathways: glycolysis (Figure 2.2), which generates intermediates for
biosynthesis and energy, and the pentose phosphate cycle, which produces NADPH
for cell anabolism and ribose for nucleic acids synthesis.
The end product of glycolysis is pyruvic acid which can be either channelled into
the tricarboxylic acid (TCA) cycle, for complete oxidation to CO2, or converted into
lactate by the lactate dehydrogenase enzyme (LDH). Three rate limiting enzymes
control the glycolytic flux: hexokinase, phosphofructokinase and pyruvate kinase .
Triose phosphate 
isomerase 
Glyceraldheyde-3-P 
deydrogenase 
Dihydroxyacetone-P 
Phosphoglycerate 
kinase 
Phosphoglycerate 
mutase 
Enolase 
Pyruvate Kinase 
Hexokinase 
Phosphogluco 
isomerase 
Phosphofructokinase 
Aldolase 
* 
* 
* 
Figure 2.2: Glucose is oxidized in the glycolitc pathway into two molecules of pyru-
vate. Concomitantly two ATP and two NADH are generated. Involved enzymes are
framed. Branch points for the pentose phosphate pathway are indicated by a star.
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Fast growing cells rapidly consume high amounts of glucose and convert it mainly
to lactate. This phenomenon was first studied in cancer cells and is known as War-
burg effect or aerobic glycolysis, since it occurs even in presence of enough oxygen
(Warburg, 1956). Different hypothesis have been proposed to explain this behaviour.
As illustrated in Figure 2.3, for each molecule of glucose that is converted into pyru-
vate two molecules of ATP and two of NADH are generated. Previous studies re-
2 2 
Figure 2.3: Pyruvate conversion to lactate allows NADH recycling but reduces its pro-
gression into the TCA cycle.
ported that if the glycolytic flux is sufficiently high, the ATP outcome can rapidly fulfil
cell needs without a complete substrate oxidation in the mitochondria (DeBerardinis
et al., 2008). Nevertheless, NADH must also be recycled to enable the maintenance of
the gycolytic flux. This can often occur through the reduction of pyruvate into lactate.
Alternatively, NAD+ can be regenerated in the mitochondria, but this requires the ac-
tivity of two shuttle systems: the malate/aspartate shuttle or the glycerol-3phosphate
shuttle, which could be a bottleneck if the glycolytic rate is too high (Bender et al.,
2006; Mulukutla et al., 2010).
Other hypothesis to explain aerobic glycolysis speculate about an extensive glu-
cose uptake that would exceed the oxidative capacity of the TCA cycle (DeBerardinis
et al., 2008), thus causing an accumulation of pyruvate and its subsequent conver-
sion into lactate. The deficiency of anaplerotic reactions, such as those catalysed
by the pyruvate carboxilase and phosphoenolpyruvate carboxykinase, would result
in the same pyruvate accumulation (Godia and Cairo, 2006; Neermann and Wagner,
1996). Overall, the consequence of the restricted pyruvate entry into the TCA cycle
would be a reduction of the mitochondrial oxidative activity.
Finally, lactate production has also been proposed as a protection mechanism to
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decrease the mitochondrial oxidative metabolism and the consequent reactive oxy-
gen species (ROS) accumulation (Brand, 1997). Indeed, during normal respiration,
single electrons can leak to O2 giving rise to the production of reactive oxygen species
(Brand, 2010). At high concentration, ROS can induce apoptosis if the detoxification
capability of glutathione is exceeded. Therefore, it has been hypothesized that can-
cer cells engage in high aerobic glycolysis to protect against ROS-mediated apopto-
sis, while fulfilling their energy need. Indeed, this behaviour is largely studied as a
system to therapeutically target cancer cells (Ralph et al., 2010).
In addition, aerobic glycolysis can be induced by the activation of the hypoxia-
inducible factor 1α (HIF-1α). This transcription factor, normally activated by condi-
tion of low oxygen availability, promotes the expression of different genes involved
in glycolysis, such as: the glucose transporter GLUT1, the hexokinase, LDH and the
pyruvate dehydrogenase kinase (PDK). PDK, in particular, inhibits the pyruvate de-
hydrogenase enzyme, hence reducing pyruvate progression into the TCA cycle. More-
over, HIF-1α also regulates mitochondrial biogenesis by inhibiting the expression
of the peroxisome proliferator-activated receptor gamma coactivator-1β (PGC-1β),
(Aragonés et al., 2009; Houtkooper et al., 2012). The activation of this system allows
the cells to switch to glycolysis and slow down mitochondrial oxidative metabolism,
which is instead oxygen dependent. Interestingly, constitutive HIF-1α expression
has been reported in several cancer cell lines and its activity seems to be activated by
glucose, pyruvate and lactate (Lu et al., 2002).
In conclusion, lactate production can be the result of a complex regulation of
glucose metabolism, which reflects the extraordinary cells adaptability to environ-
mental changes.
2.2 TCA cycle and glutamine metabolism
The TCA cycle is a major source of energy for cells since it generates three molecules
of NADH, one of FADH2 and one GTP at each cycle (Figure 2.4).
Moreover, it provides necessary intermediates for other metabolic and biosyn-
thetic pathways. For instance, during cell proliferation a part of the carbon that en-
ters the TCA cycle is diverted into lipid synthesis. This pathway requires citrate efflux
from the mitochondria and its conversion to oxaloacetic acid (OAA) and the lipogenic
precursor acetyl-CoA. OAA is then metabolised to pyruvate in order to produce the
NADPH required for anabolic reactions (Figure 2.5). This truncated TCA cycle causes
also a reduction of the flux from citrate to α-ketoglutarate (α-KG).
Glutamine, however, is able to replenish the cycle fulfilling cells energy need. In-
deed, glutamine is first deaminated to glutamate, which is then converted to α-KG,
either by deamination or transaminase reaction. Transaminases catalyse the produc-
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Figure 2.4: Pyruvate enters into the TCA cycle by conversion to Acetyl-CoA. Involved
enzymes are framed.
tion of the amino acids alanine or aspartate through glutamate reaction with pyru-
vate or oxaloacetate, respectively (Godia and Cairo, 2006). Therefore, glutamine is
relevant not only for energy production but also for intermediates synthesis.
In rich media, glutamine can also be partially oxidized to malate which is then
converted into pyruvate and lactate in the cytosol (Fig. 2.5). This metabolism, known
as glutaminolysis, provides the cells with further NADPH for biosysnthesis. More-
over, it avoids malate build up, if its production is not balanced by an adequate
acetyl-CoA availability that is necessary for the TCA cycle progression. Interestingly,
in tumour cells glutaminolysis represents the major source of NADPH and more than
the half of the glutamine-derived carbon is secreted as lactate and alanine (DeBerar-
dinis et al., 2007).
Glutaminolysis and glycolysis are both considered as hallmarks of cancer cells
or fast proliferating cells metabolism. Therefore the regulation of these pathways
is of great interest, not only for cancer research to specifically target tumour cells
(Gogvadze et al., 2008; Jones and Thompson, 2009), but also for industrial cell culture.
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Figure 2.5: The TCA cycle allows lipogenic precursor synthesis through the inter-
mediate citrate. Glutamine can also promote lactate accumulation through the
glutaminolytic pathway. ACL, ATP-citrate lyase; ACC, acetyl-CoA carboxylase; FAS,
fatty acid synthase; ME, malic enzyme; Ac-CoA, acetyl-CoA; Mal-CoA, malonyl-CoA;
MDH, malate dehydrogenase; LDH-A, lactate dehydrogenase-A; GLS, glutaminase.
Adapted from Deberardinis et al. (2008)
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2.3 Oxidative phosphorylation
The NADH and FADH2, produced during glycolysis and the TCA cycle, are reoxidised
in the mitochondrial respiratory chain (Figure 2.6). Electrons are transferred from
these reducing equivalents through four inner-membrane protein complexes to the
final acceptor, oxygen, that is then converted into water. Precisely, NADH transfers
its electrons to the Complex I/NADH coenzyme Q reductase, while FADH2 to the
complex II/Succinate CoQ reductase. Electrons are then transported to the com-
plex III/Cytochrome c reductase and Complex IV/cytochrome c oxidase. Concur-
rently, H+ are transferred in the inter-membrane space establishing an electrochem-
ical gradient, known as mitochondrial membrane potential (∆Ψm). Hence, protons
are the driving force for ATP production by the F0F1 ATP synthase complex (Fernie
et al., 2004). Three molecules of ATP are produced from each oxidized NADH and
two from FADH2. Oxidative phosphorylation represents therefore the most efficient
metabolism in terms of energy yield.
Figure 2.6: The mitochondrial respiratory chain. Adapted from (Brownlee, 2001)

3Strategies to improve cell metabolism
An optimal culture process should be characterized by a fast growth phase, where
most of the energy is used to rapidly reach a high biomass, followed by a sustained
stationary phase, where the energy is diverted to the production of the protein of
interest. Therefore, the analysis and optimization of cell metabolism becomes fun-
damental to achieve this goal, while minimizing waste products accumulation and
viability drop.
A review of the literature on lactate metabolism in industrial culture has high-
lighted two main approaches to control its production: media optimization and cell
culture engineering.
3.1 Media composition can impact lactate profile
Glucose and glutamine, as previously reported, are the major source of energy for
a cell but they can also lead to high lactate accumulation. Indeed, Altamirano et
al. proposed the simultaneous substitution of both components with galactose and
glutamate (Altamirano et al., 2006). These alternative carbon sources have the ad-
vantage of being more slowly transported into the cell, therefore promoting a more
efficient substrate oxidation with less ammonia and lactate accumulation. However,
they have the drawback of reducing cell growth. In a previous work, instead, glu-
cose was maintained in the medium, but at low concentration, together with galac-
tose (Altamirano et al., 2000). Cell growth was consequently improved and reached
a comparable level to the growth in high glucose alone. More interestingly, lactate
metabolism switched from production to consumption, once glucose was depleted.
The reported results show the strong dependence of the cells on glycolysis, at least in
this culture system. A late switch to alanine consumption was also reported, indicat-
ing a state of energy need due to the slow galactose consumption.
Optimization of the feeding strategy can also improve lactate profile (Ma et al.,
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2009). Gagnon et al. proposed a pH controlled feeding strategy which efficiently
reduced lactate accumulation (Gagnon et al., 2011). In this scenario lactate produc-
tion, as a result of high glycolysis, induces a pH drop that is used to switch off the
glucose feeding pump. Consequently, the cells switch to lactate consumption, which
promotes pH increase and finally restores the glucose feeding. Cell growth and pro-
ductivity resulted to be improved. However, the biochemistry changes underlying
the switch of lactate metabolism were not clarified.
Metabolic profiling approaches are gaining a strong interest as a strategy to define
which metabolites are depleted during a specific cell culture process. The goal is to
design tailored feeding regime according to the needs of the cells. With this approach
Sellick et al. designed a specific pyruvate and amino acids feed for the culture of a
CHO-GS cell line, which increased cell growth rate, productivity and promoted the
switch to lactate consumption. More interestingly, the switch was maintained even
if the feed was complemented with glucose, thus showing that lactate metabolism is
not only dependent on the glycolytic rate, but a more balanced media can promote
its consumption (Sellick et al., 2011).
In a recent paper published by Genentech, (Luo et al., 2011), a positive impact
of higher copper concentration on lactate consumption was reported. Copper is the
cofactor of two important enzymes; the cytochrome C oxidase complex, that is part
of the electron transport chain, and the superoxide dismutase, which is involved in
ROS detoxification. Therefore, a link between mitochondrial oxidative capacity and
lactate metabolism was hypothesized. Moreover, in the same study, two different
recombinant CHO cell lines were compared which showed an opposite lactate pro-
file, even if maintained in the same culture condition. An impairment of the mi-
tochondrial oxidative metabolism was hypothesized for the lactate producer clone.
The work of Luo et al. highlights that a mix of medium components and unknown
intrinsic cell characteristics can influence lactate profile, thus making more difficult
the understanding and optimization of cell metabolism.
Lactate can also be considered as a nutrient in those culture conditions where
cells are able to switch to net lactate consumption. Therefore, this substrate may be
used as a feed to both supply energy to the cells and control the pH (Li et al., 2012).
As reported in the published work, this strategy also avoids alanine consumption,
which normally occurs later in culture and has the side effect of increasing NH4+
accumulation. Nevertheless, this approach implies the ability of the cell line to con-
sume lactate. However, this constraint could be bypassed by feeding with pyruvate
(Sellick et al., 2011).
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3.2 Cell engineering to target lactate production
Specific metabolic pathways can be optimized by overexpression or downregulation
of key enzymes in order to reduce lactate accumulation. In particular pyruvate entry
into mitochondria is considered as a crucial flux constraint.
A direct strategy to reduce pyruvate conversion to lactate is to silence the LDH
gene either by homologous recombination (Chen et al., 2001) or by siRNA technol-
ogy (Kim and Lee, 2007a). While this approach can lead to net reduction of lactate
accumulation, it does not entail an increased pyruvate oxidation in the mitochon-
dria. Moreover, reducing LDH activity can have the drawback of decreasing glycolytic
flux, as a consequence of the limited NAD regeneration that is normally coupled to
the pyruvate-lactate reaction. Indeed, the final lactate per glucose yield can be un-
changed, as reported by Kim et al.
To overcome this issue Zhou et al. reduced the expression of both LDH and pyru-
vate dehydrogenase kinase (Zhou et al., 2011). The last enzyme suppresses pyruvate
dehydrogenase activity and therefore reduces pyruvate progression into the TCA cy-
cle. Transfected cells showed a metabolic switch to lactate consumption and a de-
creased glucose uptake rate. The measurement of the cellular ATP content showed a
slight increase in the transfected cells, indicating a general improvement of the cell
energy state.
Another flux constraint is represented by the conversion of pyruvate into oxaloac-
etate. This anaplerotic reaction is catalysed by pyruvate carboxylase (PC), which was
reported to be absent or expressed at very low levels in CHO cells (Neermann and
Wagner, 1996). Its overexpression induced a decrease of the lactate production rate
and improved cell viability (Irani et al., 1999; Fogolín et al., 2004; Kim and Lee, 2007b).
In particular, in the first two cited works, the authors used the yeast PC for the recom-
binant clone generation. This enzyme is cytosolic and not mitochondrial, as the one
of higher eukaryotes. Therefore, the produced oxaloacetate needed to be reduced
into malate to enter the mitochondrion. With this elegant strategy, not only pyru-
vate entry into the TCA cycle was improved, but NADH was also recycled, probably
reducing even further the LDH activity. Recombinant clones also showed a lower glu-
cose consumption, probably due to a more efficient use of the carbon sources, and a
slight improvement of the lactate/glucose ratio. Nevertheless, the metabolic switch
to lactate consumption was not reported.
Malate oxidation to oxalocetic acid, catalysed by the enzyme malate dehydroge-
nase II (MDH II), also represents a putative bottleneck in the TCA cycle progression.
As already reported for glutaminolysis (see section 2.2 and figure 2.5 on page 26), this
flux constraint can cause an efflux of malate out of mitochondria and its conversion
into lactate. MDHII overexpression in CHO cells, indeed, reduced the specific lactate
secretion rate and increased total ATP production (Chong et al., 2010). However, the
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impact on the glycolytic flux is unknown, since data about glucose consumption rate
were not reported.
Finally, cells engineering to allow growth on slowly metabolised sugars, such as
galactose and fructose, has been also proposed (Wlaschin and Hu, 2007; Jiménez
et al., 2011).
In conclusion, the presented strategies, while managed to improve lactate pro-
file to a certain extent, are not based on a genomic approach to specifically identify
candidates clearly linked to lactate consumption ability. Moreover, cell metabolism
is tightly regulated and interconnected, therefore any attempt to modify a specific
flux rate can have an impact on another branch. Anaplerotic reactions and redun-
dant enzyme isoforms can jeopardize the cell engineering approaches used, as an
example, to downregulate undesired pathways. Therefore, the development of a cell
host with an optimal metabolic profile can be a challenging task that requires further
investigation with a more system oriented view.
3.3 New insights in lactate metabolism
Lactate has for long been considered only as a waste product. However, lactate can
also exert a metabolic control over glycolysis, through the inhibition of the phospho-
fructokinase (PFK) enzyme (Leite et al., 2011). PFK catalyse a rate limiting step of the
glycolytic pathway. In a recent paper, published by Mulukutla et al., the metabolic
switch of NS0 cells was modelled by integrating metabolic flux data with transcrip-
tome analysis (Mulukutla et al., 2012). In most conditions, lactate net consumption
occurs when its level in the medium is high and the glycolytic rate is low. However in
some cases, lactate can be consumed even when glucose is still present at relatively
high concentrations. Interestingly, this phenomenon was modelled by adding the in-
hibitory effect of lactate on the PFK enzyme, which would result in a slowing down
of the glycolytic flux meanwhile lactate consumption occurs. Nevertheless, the con-
sumption phase can be sustained to a residual lactate concentration that is beyond
the inhibitory level. In this phase, the transcriptome analysis identified a reduced
activity of the AKT signalling.
AKT is a well known stimulator of glycolysis, therefore the downregulation of its
signalling cascade can explain the low glycolytic flux which takes place when lactate
inhibition over PFK is no more occurring. In this way, AKT inhibition simulates a con-
dition of low glucose which prompts the cell to consume lactate as alternative source
of energy. This study clearly emphasizes the complexity of cell metabolism, the in-
terconnection with unexplored signalling pathways and it opens new opportunities
for cell engineering to improve lactate metabolism (Mulukutla et al., 2012).
Finally, recent research has focused on the capability of mitochondria to metabo-
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lize lactate. Passarella et al. has reported the existence of a mitochondrial LDH in the
inner mitochondrial compartment of different mammalian tissues (Passarella et al.,
2008). Lactate entry into the mitochondria occurs through three different trans-
porters: a lactate/H+ symporter and a lactate/pyruvate and lactate/oxaloacetate an-
tiporters. Even if the existence of a mitochondrial LDH in CHO cells has not been
proven yet, these new findings provide new hints in the understanding, and mod-
elling, of lactate metabolism.

4Research objectives
The aim of this thesis project is to study lactate metabolism in CHO cells during batch
culture in chemically defined media. The main model consists of two non recom-
binant CHO cell lines, which differ in their lactate profile under the same culture
conditions. The objective is to identify the main causes of lactate over-production
and provide some tools to control it. The approaches to tackle this phenomenon are
divided in four parts:
• The first question to address is the identification of the prominent sources of
lactate production. As described before, lactate can mainly arise from glycoly-
sis or from glutamine partial oxidation in the TCA cycle, or from both of them.
Therefore the impact of these carbon sources on lactate metabolism in both
model cells lines is evaluated.
• Mitochondria play a key role in lactate metabolism and they can be consid-
ered as the hub of different pathways which can lead to lactate accumulation.
Namely, the pyruvate progression into the TCA cycle, the flux constraints at
the level of malate oxidation to oxaloacetate and the NADH shuttling from the
cytosol. A general overview of the mitochondrial oxidative capacity can be ob-
tained by measuring the mitochondrial membrane potential and oxygen con-
sumption. This type of analysis, if applied on cell lines with different lactate
profiles, can highlight possible mitochondrial impairment and thus focus our
attention on this organelle.
• Cell engineering can be an interesting tool to improve cell metabolism. The
availability of cell lines or culture conditions with different lactate profiles rep-
resents an attractive model to evaluate the expression level of different en-
zymes and transporters. The aim is to identify specific genes which expres-
sion correlates with different lactate profiles. Then the effect of their over-
expression on cell metabolism can be evaluated.
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• Most of the attempt to improve cell metabolism are specific to the tested cell
line or to the culture condition. Therefore, in this project, different media and
recombinant cells are tested in order to develop a more general approach and
to validate the hypothesis generated with the main culture model.
Material & Methods
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5Material & Methods
5.1 Reagents
Unless differently stated, all chemicals were from Sigma-Aldrich GmbH (Buchs, Switzer-
land) and suitable for cell culture.
5.2 Cell lines
Suspension adapted CHO-S cells, referred in the text as control cell line, were from
Life Technologies (Zug Switzerland). The subclone was derived from the parental
CHO-S cells by limiting dilution in medium 1. This subcloning test was performed by
a different operator and was independent from this thesis work. Recombinant clones
G4, C6 and A1 were CHO-GS derived cell lines which expressed the same therapeutic
protein. Recombinant clones c#T1, c#T2 and c#T6 were generated from the CHO-S
cell line by stable transfection with a timm8a carrying vector. Clones c#A4 and c#A6
were derived from the same parental cell line and overexpressed the aralar1 gene.
Stable clones, transfected with either timm8a or aralar1, were also generated from
the subclone and named sc#T2, sc#T5, sc#T6 and sc#A1, sc#A4, sc#A5, respectively.
5.2.1 Cell counting and IVC
Cell numbers and viability were measured using a Vi-Cell analyzer (Beckman Coul-
ter International S.A., Nyon, Switzerland). This equipment uses the Trypan blue dye
exclusion method.
The integral of viable cell density (IVC) was calculated using the following for-
mula:
IV Ct = IV Ct−1+
[
V Ct−1+ V Ct −V Ct−1
2
]
× (t − t1)
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Where t is time in days and VC is the viable cell density in 106 cells/mL. Cells were
passaged every 2-3 days at a density of 0.2×106 or 0.1×106 cells/mL, respectively.
Unless otherwise mentioned, cells were seeded by centrifugation at a density of
0.05×106 cells/mL for the growth curves. The assays were monitored for 12-14 days,
until the viability drop significantly.
5.3 Culture conditions and media
Cells were cultivated in 50 mL TubeSpin® (TPP AG, Trasadingen, Switzerland) in
orbitally shaken incubator at 37°C, 5% CO2 and 80 % humidity (Adolf Kuhner AG,
Birsfelden, Switzerland). All media were chemically defined. Two proprietary media
(medium 1 and 2) or alternatively the commercially available CD CHO medium ( Life
technologies, Zug, Switzerland) were used. Initial glutamine concentration was set at
4.5 mM in all tested media. After glutamine supplementation, media were sterile fil-
tered and stored at 4°C in the dark for a maximum of three months. Unless differently
stated, all the growth assays were performed as batch in 20 mL of medium.
5.3.1 Culture conditions for specific tests
For the feeding test, glutamine was diluted in water at a concentration of 200 mM
and then supplemented to the cells on day 5 of growth. Two final feed levels were
tested: 4 and 6mM.
The factorial design was performed using a from scratch preparation of medium
2 deficient in copper, biotin and alanine. Concentrated stock solution of alanine (600
mM) and copper (1mM) were prepared in water and supplemented, when necessary,
to the cells on day 0. Biotin solution (1mM) was instead prepared in 0.01 M NaOH.
Data analysis was performed using the Design Expert Software (Version 8.0.1, Stat-
Ease Inc, Minneapolis, USA).
The inhibition test with aminooxyacetic acid required first a dose-response curve
to identify the best concentration. Control cells were seeded in medium 1 at a den-
sity of 0,2× 106 cells/mL. The concentration of 0,25 mM was finally selected. This
represented the lowest concentration which still impacted lactate metabolism with-
out impairing cell growth. AOAA was added directly to the culture medium on day 0.
pH was adjusted by equimolar addition of NaOH.
The fed-batch culture for the gene expression analysis was performed by growing
the recombinant cell line A1 in CD CHO medium in spin tubes. The culture volume
was set at 30 mL. Two different feeds (feed1 and feed2) were added from day 3 to
day 12 or on day 4,7 and 10, respectively. The culture was executed by a different
operator.
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5.4 Metabolites measurement
Glucose, glutamine, lactate, pH and NH4+ in cell culture supernatant were measured
using a NOVA Biomedical analyzer (Nova Biomedical GmbH, Rödermark, Germany).
Amino acids concentration was measured in cell culture supernatant on differ-
ent days of growth. The test was performed by the Analytical group at Merck-Serono.
Briefly, samples were harvested on day 5, 7, 10 and 12 of cell culture and centrifuged
for 5 minutes at 300 g. The supernatant was then clarified with a 0.45 µm filter. The
amino acids analysis was performed using a commercially available kit, AccQ-Tag Ul-
tra Derivation kit (Waters AG, Montreux-Chailly, Switzerland) with a UPLC column,
according to manufacturer’s guidelines.
5.5 Mitochondrial metabolism
5.5.1 Oxygen consumption measurement
Oxygen consumption was measured using the PreSens Oxoplate (Precision Sensing
GmbH, Regensburg, Germany). These 96 well plates have a round bottom equipped
with an oxygen sensor. Two dyes are included in the sensor: an indicator, which flu-
orescence is oxygen dependent, and a reference, which is O2 independent and used
to normalize the well to well discrepancy. Cells, on different days of culture, were
resuspended at a concentration of 106 cells /mL in spent medium. 200 µl were used
for the test. The assay was carried out using a Spectramax Gemini EM fluorometer
(Molecular Devices, Sunnyvale, CA, USA) and fluorescence emission was monitored
for 45’, with a reading every minute, at 37°C ( excitation 540 nm; and emission 650
and 590 nm for indicator and reference signal, respectively).
Oxygen pO2 values as % of air saturation were calculated after calibration using
the following formula:
pO2 = 100×
K0
Ir
−1
K0
K100
−1
Where Ir is the ratio between the indicator and reference fluorescence intensity
for each sample. K0 is the Ir value obtained with the 0% oxygen calibrator, which
was prepared by diluting 1g of Na2SO3 in 100 mL of water. K100 is the Ir value given
by the 100% oxygen calibrator, which was made by agitating 50 mL of water for one
minute. pO2 values were plotted over time to calculate the oxygen consumption rate
from the slope. Finally, for each day of testing, values were normalized and expressed
as percentage of the lactate consuming condition, which was set at 100 % .
Two controls were also used. Oligomycin, an inhibitor of the F0 /F1 ATP syn-
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thase, was added at a final concentration of 1 µM to evaluate the residual oxygen
consumption due to proton leaking. Antimycin A, an inhibitor of the Complex III of
the respiratory chain, was used at a final concentration of 10µg/mL to evaluate resid-
ual oxidative reactions not due to mitochondrial respiration. Spent media were also
tested to check for possible interference of media components with the fluorescence
detection.
5.5.2 Mitochondrial membrane potential
Mitochondrial membrane potential was measured in 105 intact cells with 100 nM
TMRE (Biotium Inc., Hayward, CA, USA). TMRE stock solution was prepared by dis-
solving the powder in DMSO at a concentration of 1mM and was stored at -20°C.
The protonophore CCCP was dissolved at a concentration of 1 mg/mL in DMSO and
stored at 4°C. Working solutions of TMRE and CCCP were prepared freshly in PBS.
Cells were harvested on different days of culture, centrifuged for 5 minutes at 300g
and resuspended in spent medium for the staining. The incubation was performed
in 96-well microplate (Greiner Bio-One GmbH, Frickenhausen, Germany), covered
with a gas-permeable seal (Diversified Biotech, Dedham, MA, USA) for 20 minutes
at 37°C. The cells were washed in PBS prior to flow cytometry analysis using a Guava
PCA 96 equipment (Millipore, Molsheim, France).
TMRE is a lipophilic, cationic fluorescent dye that accumulates within mitochon-
dria proportionally to the membrane potential. At the used concentration TMRE
works in a quenched manner, therefore, CCCP addition (final concentration 10 µM)
induces an increase of fluorescence as a result of dye redistribution in the cytosol
(Chalmers and McCarron, 2008; Scaduto and Grotyohann, 1999). The ratio of fluo-
rescence increase, under the same incubation conditions, was used as an indication
of the mitochondrial membrane potential. For each test, normalized values were
calculated as percentage of the lactate consuming condition, which was set at 100 %
.
5.6 Gene expression assay
5.6.1 RNA extraction and cDNA preparation
RNA was extracted from 5×106 cells harvested on different days of culture. Cells were
centrifuged for 5 minutes at 300 g and the total RNA isolation was performed using
the RNeasy Mini kit (Qiagen AG, Basel, Switzerland) according to manufacturer’s pro-
tocol. RNA concentration and quality was estimated spectrophotometrically with a
Spectramax Plus384 spectrophotometer (Molecular Devices, Sunnyvale, CA, USA) by
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measuring the absorbance at 260 and 280 nm. Samples were stored at -20°C un-
til use. Retrotranscription was performed with the High Capacity RNA-to-cDNA kit
(Life Technologies, Zug, Switzerland) using 1 µg of RNA for each sample. cDNA was
stored at -20°C until use.
5.6.2 Real-time PCR assay
The gene expression array was performed with a custom TaqMan® Array 96 well
Plate, including 3 endogenous control genes (18S, GAPDH and HPRT) and run on
a 7500 Fast Real time PCR (Life Technologies, Zug, Switzerland). GAPDH was finally
selected as endogenous reference gene. 50 or 100 ng of cDNA were used for each
test and were diluted in the TaqMan® gene expression Master Mix, following man-
ufacturer’s instructions. The array was charged with murine primers and probes,
since CHO specific sequence were not available at the time of the test. However, a
high homology between the Chinese hamster and mouse genome has been reported
(Yee et al., 2008b). For the individual amplification of aralar1 and timm8a the same
primers and probes of the array were used. Primers efficiency was evaluated for these
genes and for the reference, GAPDH, by serial 1:10 dilution of the cDNA. The ob-
tained Ct values were plotted versus the logarithm of cDNA concentration and the
slope was used to calculate the amplification efficiency, using the following formula:
E = 10 −1sl ope −1
Where E is the efficiency. The required 100±10 % efficiency was obtained for all
primers.
Real-time PCR data were analysed applying the comparative ∆∆Ct method ac-
cording to manufacturer’s guidelines. More precisely, the lactate consuming condi-
tions was always used as reference sample and expression differences were reported
as fold change. The Data Assist software (Life Technologies, Zug, Switzerland) was
also used as support to confirm the data analysis.
5.7 Recombinant clone generation
Control and subclone cells were transfected with a pCMV6-AC-GFP vector contain-
ing either the mouse aralar1 or timm8a ORF sequence cloned upstream the GFP-tag
(ORIGENE Technologies, Rockville, USA). The vector carried also the neomycin re-
sistance gene. The transfection was performed in suspension culture in medium 1.
The X-treme GENE HP DNA Transfection Reagent (Roche AG, Rotkreuz, Switzerland)
was used as liposome based gene transfer method. A reagent:DNA ratio of 2:1 was
selected and 2 µg of plasmid DNA was used for each transfection.
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Cells were counted and resuspended in fresh medium 1 at a concentration of 5×
106 cells/mL. The reagent-DNA mix, after 10 minutes of pre-incubation, was added
to 600 µL of cells. After two hours of standard incubation, cells were diluted by
adding 6 mL of fresh medium. Two days post transfection, cells were resuspended in
medium 1 supplemented with 800 µg/mL of G418 for stable transfectants selection.
The antibiotic concentration was decided by performing a kill curve with untrans-
fected cells. The chosen level was the one that gave complete cell death in around 10
days.
After three weeks of selection, the four stable pools were used for single clones
isolation by limiting dilution method. Briefly, cells were diluted in medium 1 con-
taining 0.3% of phenol red, which allowed to monitor the cell growth, and dispensed
in 384 wells plates using an automatic sampler. After two weeks, selected colonies
were transferred in a stepwise manner to 96, 24 and 6 well plates with almost one
week of monitoring for each step. GFP fluorescence was measured during the entire
selection process using a Guava PCA 96 flow cytometer (Millipore, Molsheim, France)
in order to identify the most stable clones. Finally, colonies were transferred from the
6 wells plate to spin tubes and cultivated according to the standard protocol. The sta-
ble clones which adapted to the suspension culture were used for the growth assay.
The flow cytometry graphs were generated using the Flow JO software (Tree Star
Inc, Ashland, OR, USA).
5.8 Fluorescent microscopy
The colocalization assay was performed by staining the cells with a specific mito-
chondrial dye, Mitotracker Red CM-H2XRos (Life Technologies, Zug, Switzerland).
This dye does not fluoresce until it enters a living cells, where it is then oxidised in
the fluorescent probe and sequestered into the mitochondria. A stock solution was
prepared by diluting the dye in DMSO at a concentration of 1mM and stored at -20°C.
The working solution was then prepared fresh in medium 1. Aralar1 and timm8a pro-
teins were visualized thanks to the GFP tag. Briefly, cells were centrifuged for 5 min-
utes at 300 g and resuspended in fresh medium at a concentration of 106 cells/mL.
The staining was performed with 200 nM of Mitotracker for 15 minutes at 37°C. Af-
terwards, cells were washed in PBS and drops were spread on a Superfrost plus slide
(Fisher Scientific AG, Wohlen, Switzerland). Images were acquired with a motor-
ized Axiovert 200 M fluorescent microscope (Carl Zeiss AG, Feldebach, Switzerland)
equipped with a 63x objective. A HBO 100 lamp was used as a fluorescence excitation
source. A Zeiss AxioCa HRm camera was mounted on the microscope, and image
acquisition was controlled by the Axiovision 4.1 software (Carl Zeiss AG, Feldebach,
Switzerland).
Results & discussion
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6CHO cell metabolism analysis
6.1 Introduction to the culture model
The analysis of cell metabolism can be a challenging task since both environmen-
tal and cell characteristics can interfere with the investigated pathway. An optimal
condition to study lactate metabolism would be to compare two cell lines, which are
apparently identical, but show opposite lactate profile when grown in the same cul-
ture condition. This approach has the advantage of reducing external contributions,
such as changes of media composition, temperature shift or transgene integration,
which can also be used to induce a switch to lactate consumption, but at the same
time can perturb different metabolic pathways and introduce further variables.
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Figure 6.1: Lactate profile of the parental cell line (black circles) and the isolated sub-
clones (dashed lines). The one with the highest lactate production was selected for
the project (grey squares).
Hence, in this study two non recombinant CHO cell lines were used, which differ
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in their lactate metabolism even if cultivated in the same chemically defined medium
(referred next as medium 1). More precisely, one cell line is the commercially avail-
able CHO-S cells (referred next as control cell line). The second is a subpopulation of
the control (referred next as subclone) obtained during an independent subcloning
experiment.
The subcloning was performed by a limited dilution strategy in medium 1 with
the aim of isolating a new clone which grew more and with less clumps. Among the
ten isolated subclones, eight retained the ability to switch to net lactate consump-
tion, as the control cell line, while two showed a continuous lactate accumulation.
Within the last group, the subclone with the highest lactate production was selected
for the study (Fig. 6.1, grey squares). This characteristic was retained after freezing
and thaw and throughout the entire study.
6.2 Growth and metabolic profile
The two cell lines were characterized for their growth and metabolism in medium
1. As reported in figure 6.2 A and B, both the control cells and the subclone showed
a similar exponential growth and viability, with a the peak occurring on day 9. The
decline phase, however, was less abrupt in the subclone. Glutamine, glucose and
glutamate (Fig. 6.2 C, D and G respectively) consumption were identical for both
cell lines, whereas lactate profile (Fig. 6.2 E) clearly differed. During the first 5 days
of growth, both cell lines produced lactate to the same extent. Afterwards, only the
control cells switched to net consumption. On the contrary, the subclone, after a
steady phase, continued to accumulate lactate until day 9. A pH drop to 6,8 was also
observed during this phase (Fig. 6.2 F). Eventually, even the subclone switched to a
partial consumption at the end of the culture.
Interestingly, the metabolic switch in the control cells occured at the time point
when glutamine was almost depleted, and glucose and lactate were consumed si-
multaneously. On the contrary, the subclone preferred to engage in glycolysis and
used lactate only when also the residual glucose was at low concentration in the
medium. Probably, the higher subclone viability at the end of the culture was sup-
ported by this late lactate consumption. A different preference in the use of the avail-
able carbon sources was, therefore, assumed for the two cell lines.
The amino acids profile also showed a similar consumption between the two cell
lines, with the exception of alanine and serine (Fig. 6.3). Alanine metabolism was
characterized by an initial production phase, probably during period of high nutri-
ents availability, and then switched to consumption on day 10, when residual sub-
strates were at lower concentration. Interestingly, while the switch occurred at the
same moment for both cell lines, a stronger consumption was observed in the sub-
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Figure 6.2: Control cell line (circles) and subclone (squares) growth and metabolic
profiles in medium 1. Representative graph of several experiments. Mean± standard
deviation from duplicate cultures.
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Figure 6.3: Residual amino acids concentrations are reported for the subclone as nor-
malized values against the control cell line on day 5, 7 , 10 and 12 of cell growth in
medium 1. Mean from duplicate cultures, standard deviations are not reported for
better clarity.
clone. Alanine can be converted to pyruvate by the alanine aminotransferase enzyme
and, hence, replenish the TCA cycle instead of lactate. Serine consumption was also
more prominent in the subclone after day 7. Serine is also a glucogenic amino acids
and is converted to either pyruvate or 3-P-glyceric acid. This higher amino acids
consumption could also account for the increased ammonia accumulation observed
in the subclone (Fig. 6.2 H). Cysteine, glutamine and asparagine were undetectable
after day 5 or 7 in both cell lines supernatant.
6.3 Glutamine influences the metabolic shift in control
cells
Glutamine depletion was reported to be concurrent with the switch to lactate con-
sumption in the control cell line, as shown in figure 6.2 C and E.
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To better investigate its role on lactate metabolism, both cell lines were fed with
4 mM or 6 mM of glutamine on day 5, when its residual concentration was low and
the switch normally occured (Fig. 6.4 B, control cell line and F, subclone).
Interestingly, the feeding induced an almost stoichiometric increase of lactate
levels and a delay of its consumption in the control cell line (Fig. 6.4 D). Precisely,
the measured increase was of 0,32 g/L and 0,5 g/L for the 4mM and 6mM feed, re-
spectively, which fits the 1:1 conversion due to the glutaminolytic pathway. This
behaviour clearly indicated glutamine as an important factor in modulating lactate
metabolism in this cell line.
A higher lactate production was also observed in the subclone (Fig. 6.4 H), al-
though consumption never occurred, probably due to glycolysis contribution. Glu-
cose consumption rates and cell growth were not significantly impacted by the glu-
tamine feeds in both cell lines (Fig. 6.4 C and G, A and E, respectively).
6.4 Glucose impacts lactate metabolism only in the sub-
clone
Glucose can be the main source of lactate production in a cell as a result of glycol-
ysis. In section 6.2, a correlation between glucose consumption and higher lactate
accumulation was observed only in the subclone.
In order to better explore this behaviour, both cell lines were cultivated in media
with increasing glucose concentrations; precisely with 8, 10 and 12 g/L (Fig. 6.5 B,
control cells and F, subclone).
The control cell line was not impacted by this higher glucose availability, since
the metabolic switch occurred always on day 5 (Fig. 6.5 C). However, a steady phase
was observed towards the end of the culture in the case of the richest media. It is
likely that this phenomenon was linked to the extended viability and the depletion
of other limiting metabolites.
As expected, the increasing glucose concentrations delayed the lactate metabolic
switch in the subclone, precisely from day 9 in the medium containing 8 g/L of glu-
cose, to day 12 in the 10 g/l medium (Fig. 6.5 F and G). In the richest medium a slight
consumption was observed on day 14, but due to the strong cell death it was not pos-
sible to better characterize it. Interestingly, lactate consumption started always when
glucose was almost depleted.
Glucose consumption (Fig. 6.5 B and F) and growth profiles (Fig. 6.5 A and E) were
similar in all tested conditions, with the richer media showing a prolonged viability
until day 14 in the control cell line. Glutamine profile was not impacted as well (Fig.
6.5 D and H).
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Figure 6.4: Metabolic profile of the control cell line (A to D) and the subclone (E to
H) in medium 1 after glutamine feeding. Two feeds were added on day 5: 4 mM
(triangles) or 6 mM (diamonds). Control condition is indicated by filled symbols.
Mean ± standard deviation from two independent tests.
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Figure 6.5: Metabolic profile of the control cell line (A to D) and the subclone (E to H)
in medium 1 with different initial glucose levels. Three concentrations were tested: 8
(standard concentration, filled symbol), 10 (triangles) and 12 g/L (diamonds). Mean
± standard deviation from two independent experiments performed with duplicates.
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These results confirmed the hypothesis that the subclone preferred to use glu-
tamine and glucose as main energy sources and only after their depletion it switched
to lactate. Probably, some unknown limiting factors either inhibited lactate con-
sumption or slowed it down to an extent that did not counterbalance its production
from glycolysis, thus resulting in a higher accumulation.
6.5 Discussion
Reported results indicate that the two cell lines have a different preference for the
available energy sources. In particular:
• During the first 5 days of culture, both the control and the subclone behave
similarly and accumulate lactate. The production phase persists as long as glu-
tamine is present in the medium. Glutaminolysis was already described as a
relevant pathway for lactate production in cancer cells. This metabolism re-
quires the efflux of malate out of the mitochondria and its conversion to pyru-
vate, and finally into lactate, with production of NADPH (DeBerardinis et al.,
2007). Most likely, our fast growing cells undergo the same metabolic pathway
in order to fulfill their NADPH need for anabolic processes, which are particu-
larly active during the exponential growth phase. Other amino acids can also
contribute to the malate build up and indeed the amount of lactate accumu-
lated on day 5 is not stoichiometric with the glutamine consumption alone.
Glucose consumption is quite limited till day 5, however its contribution to
lactate accumulation can not be excluded (Fig. 6.2).
• After glutamine depletion, the two cell lines show an opposite behaviour. The
control cells switch to net lactate consumption, which is likely used to replen-
ish the TCA cycle. Glucose is also simultaneously consumed. Interestingly, the
metabolic switch occurs when the cells are still in the exponential growth phase
and is concomitant with glutamine depletion. Therefore, glutamine seems to
strongly modulate lactate metabolism, as it was also demonstrated with the
feeding experiment (Fig. 6.4). This finding differs from literature examples,
where lactate consumption is often associated to cell entry into the stationary
phase and to a reduction of glucose consumption (Li et al., 2012; Ma et al., 2009;
Mulukutla et al., 2012).
• Glucose promotes higher lactate accumulation only in the subclone. In this
cell line the metabolic shift to consumption occurs only when both glucose
and glutamine are depleted and the cells stop to grow. This behaviour is more
in agreement with the previously reported literature examples. This greater
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lactate production most probably reduces the amount of pyruvate which pro-
ceeds into the TCA cycle, with a consequent impact on the mitochondrial ox-
idative metabolism.
Different causes can be postulated: a saturation of the TCA cycle or carriers
impairment which reduces the intermediates entry into the mitochondria. A
higher expression of the LDH-A subunit, which has been associated to lactate
production instead of oxidation (Kim and Lee, 2007a), could be hypothesized
as well. Overall, all these conditions would most likely induce a reduced mito-
chondrial activity in the subclone.
Other substrates could be used by the subclone to overcome the lower pyru-
vate entry in the TCA cycle. Alanine could be an example. Indeed, this amino
acids is normally produced and excreted in situation of high nutrients avail-
ability. Afterwards, when the preferred carbon sources are depleted, cells start
to consume alanine through conversion into pyruvate (Li et al., 2012; Gambhir
et al., 2003). Indeed, a stronger alanine consumption was observed for the sub-
clone, after day 7, compared to the control cells. Nevertheless, the difference
was not enough to compensate for the amount of pyruvate diverted toward lac-
tate production. Fatty acids oxidation could also be used to compensate for the
reduced pyruvate oxidation in the subclone mitochondria. However, consider-
ing that the cells are in exponential growth and medium 1 contains only an
unsaturated fatty acid in µg amount, it is more likely that lipids are produced
in this phase, for the build up of new cells membrane, than oxidised (Schaub
et al., 2010).
In conclusion, a condition of reduced mitochondrial activity in the subclone
seemed to be an attractive hypothsis which needed further investigations.

7Mitochondrial metabolism analysis
7.1 Introduction
Mitochondria are double membranes organelles which have a central role in differ-
ent cell processes, such as: energy and intermediates production, apoptosis, reactive
oxygen species (ROS) generation and Ca2+ homeostasis. In the last decades, mito-
chondria have been extensively studied, in particular in association to several dis-
eases, as neurodegenerative disorders, diabetes and normal tissues ageing, which
have been linked to specific mitochondria dysfunctions (Greaves et al., 2012; Maech-
ler et al., 2010).
According to the endosymbiotic theory, this organelle is the result of the incorpo-
ration of an aerobic bacterium by the primordial eukaryotic cell. Indeed, mitochon-
dria contain their own genome, a double stranded circular molecule of 16 Kb, which
is considered as the residual of the bacterial DNA. The mitochondrial DNA (mtDNA)
contains 37 genes, which encode for subunits of the respiratory chain complexes I,
III and IV, the ATP synthase, 22 tRNA and 2 rRNA, needed for the translation of the
mtDNA transcripts (Chan, 2006). The other proteins required for mitochondria func-
tioning are encoded by the nuclear genome and transported to their final location by
a complex translocation system (Neupert and Herrmann, 2007).
Mitochondria are also highly dynamic organelles. Indeed, they undergo a com-
plex turnover process, which includes fission-fusion, biogenesis of new mitochon-
dria and autophagy (Grandemange et al., 2009; Diaz and Moraes, 2008). All these
mechanisms are strongly regulated by the cells energy requirements, but the signal-
ing pathways behind these phenomena, and especially the interconnection between
mitochondria dynamics and cell physiology, are still under investigation.
In this work, mitochondria have been studied for their key role in energy produc-
tion. Several approaches can be used to evaluate mitochondrial oxidative activity.
The measurement of TCA cycle enzymes rate is an example (Zhang et al., 2006; Neer-
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mann and Wagner, 1996), although it can be a time consuming strategy since several
reactions should be evaluated to get a complete view of the fluxes. Metabolite pro-
filing can also be used to monitor both extracellular and intracellular intermediates
throughout the cell culture, thus providing information about limiting nutrients or
reactions (Ma et al., 2009). Alternatively, radiolabeled carbon sources allow to mon-
itor flux distribution and, specifically, the amount of glucose and glutamine that are
completely oxidized to CO2 in mitochondria (Goudar et al., 2010; Butler et al., 1997).
However, to obtain a more general view of the oxidative capacity of the mitochondria,
the oxygen consumption rate is often measured, since it is a simple and informative
approach (Gohil et al., 2010). Indeed, O2 is the final acceptor of the mitochondrial
electron transport chain, where it is converted to water. Moreover, concomitant with
the electron flow, a proton gradient (∆Ψm) is also generated between the mitochon-
drial matrix and the intermembrane space. ∆Ψm is finally the driving force for ATP
production (see paragraph 2.3 on page 27).
In this chapter, the oxygen consumption rate and the mitochondrial membrane
potential of the two model cell lines have been compared. The aim has been to eval-
uate if the higher lactate production in the subclone could be linked to a reduced
mitochondrial metabolic activity.
7.2 Mitochondrial oxidative metabolism is reduced in
the subclone
7.2.1 Oxygen consumption rate
O2 consumption was monitored in both cell lines at different moments of culture in
medium 1. More precisely samples were harvested on day 2, when the TCA cycle was
fuelled by the high glutamine availability; on day 5, when glutamine was depleted
and the control cells switched to lactate consumption; on day 7 and 9, when the
difference in lactate metabolism was more evident between the two cell lines.
The assays to monitor the mitochondrial metabolism were not performed after
day 9 to avoid misinterpretation due to the decrease in cell viability and possible oc-
currence of apoptotic events (Grandemange et al., 2009; Tiefenthaler et al., 2001).
Indeed, the mitochondrial apoptotic pathway begins with the permeabilisation of
the outer membrane, followed by a collapse of the proton gradient and release of
cytochrome-c (Frezza et al., 2007). Consequently, the ∆Ψm and the O2 measure-
ments would be negatively impacted.
As shown in figure 7.1, the oxygen consumption in the subclone significantly
declined after the first 5 days of culture, reaching about 64% and 55 % of the con-
trol cell line on day 7 and 9, respectively. Two controls were also added to the test.
7.2. MITOCHONDRIAL OXIDATIVE METABOLISM IS REDUCED IN THE
SUBCLONE 59
0 
20 
40 
60 
80 
100 
120 
O
2 c
on
su
m
p
ti
on
 
(%
 o
f c
on
tr
ol
) 
d2 d5 d7 d9 
* ** 
Figure 7.1: Oxygen consumption was measured in both cell lines on different days
of culture in medium 1. The PreSens Oxoplate were used to monitor O2 levels for 45
minutes, with a reading every minute, at 37°C in a flurometer. Only subclone data are
reported as a percentage of the control cell line (set at 100 %) on each day of analysis.
Mean ± standard deviation from four independent tests performed with duplicates.
*, p <0,05 and **, p <0.01, Student’s t-test.
Oligomycin, an inhibitor of the ATP synthase, allowed to evaluate the extent of oxy-
gen consumption due to proton leaking. The inhibitor of the electron chain complex
III, antimycin A, was instead used to block mitochondrial respiration. In both cases,
the resulting oxygen consumption curves of the two cell lines were super-imposable
(data not shown). This confirmed that the results reported in figure 7.1 were due to a
reduced mitochondrial oxidative capacity in the subclone.
7.2.2 Mitochondrial membrane potential
The mitochondrial membrane potential was also measured in both cell lines to con-
firm the observations of the previous test.
As shown in figure 7.2, the mitochondrial membrane potential in the subclone
was comparable to the control cell line during the first 5 days of culture, while it de-
creased significantly and reached around 80% of the control on day 7, and 60% on
day 9.
Interestingly, the reduction of the mitochondrial oxidative metabolism in the sub-
clone was evident only after day 5 in both tests. At this time point, glutamine was
depleted in medium 1 (Fig. 6.2 on page 49). Therefore, other metabolites should be
used to replenish the TCA cycle. While the control cells probably oxidised lactate
to this purpose, the subclone, instead, diverted a part of the pyruvate pool to lac-
tate production. Therefore, the carbons which entered into the TCA cycle were most
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Figure 7.2: ∆Ψm was measured in both cell lines by flow cytometry, after staining
with TMRE, on different days of culture in medium 1. Only subclone measures are
reported as a percentage of the control cell line (set at 100 %) on each day of analysis.
Mean ± standard deviation from five independent tests performed with duplicates.
*, p <0,05 and **, p <0.01, Student’s t-test.
likely reduced compared to the control cell line. Hence, the metabolic behaviour ob-
served in the subclone resulted into a lower mitochondrial activity, as confimed by
the ∆Ψm and the oxygen consumption evaluation.
7.3 Media impact on mitochondrial metabolism
Two other chemically defined media were tested on both model cell lines. The goal
was to evaluate whether intrinsic cell properties were the only cause for the higher
lactate accumulation in the subclone, or media composition could also influence this
metabolism. In particular, a different proprietary medium (referred next as medium
2) and the commercially available CD CHO medium were used.
Surprisingly, in medium 2, also the subclone became able to switch to lactate
consumption after day 5 (Fig. 7.3 D). The shift occurred again at the time point when
glutamine was depleted, and both cell lines consumed glucose and lactate simul-
taneously (Fig. 7.3 B and C). The growth profile was similar to the one reported in
medium 1 (Fig. 6.2 on page 49), except for a earlier cell death in medium 2 prob-
ably due to nutrient depletion (Fig. 7.3 A and C). Lactate concentration on day 5
was higher than in medium 2, however the consumption phase was faster than in
medium 1 (Fig. 7.3 D and 6.2 E). Accordingly, the mitochondrial membrane poten-
tial and the oxygen consumption in the subclone were comparable to the control cell
line, as shown in figure 7.3 E and F.
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Figure 7.3: Control cell line (circles) and subclone (squares) growth (A) and metabolic
profiles (B, C and D) in medium 2. The mitochondrial membrane potential (E) and
oxygen consumption (F) in the subclone are expressed as a percentage of the control
cell line (set at 100 %) on each day of analysis. Mean± standard deviation from three
independent tests performed with duplicates.
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Based on these data, it can be excluded that the lower mitochondrial activity re-
ported for the subclone in medium 1 is caused by an irreversible cell characteristic.
The results indicate that a combination of both cell properties and media composi-
tion affects lactate metabolism and the mitochondrial oxidative capacity.
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Figure 7.4: Control cell line (circles) and subclone (squares) growth (A), metabolic
profiles (B, C and D) in CD CHO medium. Mean ± standard deviation from three
independent tests performed with duplicates.*, p <0.005 , Student’s t-test.
This conclusion was further validated by growing the cells in CD CHO medium.
Indeed, CD CHO triggered a higher lactate production in the control cell line, pre-
venting the metabolic switch (Fig. 7.4 D). Cell growth , glutamine and glucose pro-
files (7.4 A, B and C respectively) were similar for both cell lines and also comparable
to those observed in medium 1. However, the peak of growth was reached earlier
in CD CHO than in medium 1 and cells death was also anticipated due to glucose
depletion.
The mitochondrial membrane potential and the oxygen consumption of the con-
trol cell line in CD CHO were compared to the values obtained in medium 1. A sig-
nificant decrease on day 7 was observed for the culture in CD CHO (Fig. 7.5 A and B,
respectively), which correlated with the higher lactate accumulation observed in this
medium.
In conclusion, data hitherto reported clearly suggested that the culture medium
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Figure 7.5: The mitochondrial membrane potential (A) and oxygen consumption (B)
of the control cells in CD CHO are expressed as a percentage of the values obtained
for the same cell line in medium 1 (set at 100 %). Mean ± standard deviation from
three independent tests performed with duplicates.*, p <0.005 , Student’s t-test.
impacts lactate production. Moreover, the mitochondrial oxidative metabolism is
involved in the observed phenomenon.
7.4 Key media components impact lactate metabolism
Medium 1 and 2 composition were compared in order to identify which components
were differently present and could have an impact on lactate profile. The same anal-
ysis could not be done on CD CHO medium since its composition is not known.
Three elements had significantly different concentrations in the two media: ala-
nine, which was absent in medium 2, copper and biotin, which were more concen-
trated in medium 2.
In order to better investigate their effect on lactate metabolism, a full factorial
design was performed. Medium 2, deficient in alanine, copper and biotin, was used
as a basal medium. The three identified elements were then added according to the
levels reported in table 7.1 to obtain the final experimental matrix shown in table 7.2.
Standard medium 2 was also included and used as a control (run 7 in table 7.2).
All tested conditions showed similar growth (Fig. 7.6 A and D), glucose and glu-
tamine consumption profiles (data not shown). Lactate, instead, was significantly
influenced by alanine and copper levels. In particular, while the metabolic switch on
day 5 was maintained, the extent of consumption varied. Ammonia final concentra-
tion was also impacted.
As shown in figure 7.6 C and F, alanine supplementation increased NH+4 level at
the end of the culture in both cell lines from around 4 to 6 mmol/L (circles versus tri-
angles, p value <0.0001, ANOVA analysis). It also rose residual lactate concentration,
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Table 7.1: Each component was added to the basal medium at the concentration
normally present in medium 1 or 2. Normalized concentrations are reported as per-
centage.
Component Medium 1 Medium 2
Alanine 100 % 0%
Copper 20% 100%
Biotin 6% 100%
Table 7.2: Experimental matrix for the factorial design. Level 1 represents the high
and -1 the low concentration. Each run corresponds to a test
Levels
Run Alanine Copper Biotin
1 1 -1 1
2 1 -1 -1
3 1 1 1
4 1 1 -1
5 -1 -1 1
6 -1 -1 -1
7 -1 1 1
8 -1 1 -1
but this was significant only in the subclone (Fig.7.6 E, p < 0.005, ANOVA analysis).
A reduced copper concentration also caused an increase of lactate levels on day 9
compared to medium 2. However, its role was more significant in the subclone (Fig.
7.6, squares versus triangles. p value < 0.0005, for the subclone (E) and < 0.05, for the
control (B), ANOVA analysis). The combination of the two components increased
even further the residual lactate concentration in the subclone, but the effect was
less significant (Fig.7.6 E, diamonds. p<0.05, ANOVA analysis). Biotin had no major
effect.
In conclusion, alanine and copper were identified as key elements to take into
account when designing a medium. However, even if relevant, they were not suffi-
cient to control lactate metabolism, since the switch to consumption still occurred
and was concomitant to glutamine depletion. Furthermore, their effect was more
significant in the subclone than in control cells.
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Figure 7.6: Growth, lactate and ammonia profiles for the control cell line (A to C)
and the subclone (D to F). Standard medium 2 (triangles, run 7 and 8), alanine sup-
plementation (circles, run 3 and 4), low copper concentration (squares, run 5 and 6)
and the mix of these two conditions (diamonds, run 1 and 2) are reported. Biotin had
no effect, therefore data were lumped according to the level of the other two compo-
nents. Mean ± standard deviation from duplicate cultures.
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7.5 Discussion
The mitochondrial membrane potential and the cell oxygen consumption depend
on the activity of the electron transport chain. The respiratory chain, in turn, is con-
ditioned by the NADH availability in the mitochondria, either produced in situ or
transported from the cytosol through the shuttle systems.
Data shown in figure 7.1 and 7.2 clearly highlight the presence of an impaired
mitochondrial metabolism in the subclone, when compared to the control cell line.
Interestingly, the reduction of∆ψm and O2 consumption in the subclone is concomi-
tant with the divergence in lactate metabolism between the two cell lines. Different
hypothesis can be postulated to explain the observed behaviour.
An alteration of the electron transport chain, as an example, can cause a reduc-
tion in ∆ψm and O2 consumption. However, this should be detectable already at the
beginning of the culture, when the TCA cycle is mostly fuelled by glutamine.
The expression of an uncoupling protein can be hypothesized as well. These pro-
teins allow protons return through the mitochondrial membrane, bypassing the cou-
pling with ATP production. The result is a decrease of the mitochondrial membrane
potential, while the respiratory chain activity and oxygen consumption would be
stimulated as a mechanism to compensate for the lower ATP availability (Criscuolo
et al., 2006). Reported data, instead, showed a reduction of O2 consumption in con-
ditions of high lactate production, which, therefore, excluded the hypothesis of un-
coupling activity.
A reduced NADH/FADH2 availability in mitochondria is likely to be the main
cause, either due to a flux constraint in the TCA cycle or to a lower intermediates
availability. Indeed, the stronger lactate production in the subclone likely diverts a
part of the glycolysis-derived pyruvate from the progression into the TCA cycle. In
contrast, the control cells not only consume glucose at a rate similar to the subclone,
but they also consume lactate, thus increasing the fuelling of the mitochondrial ox-
idative metabolism. However, the reason why the subclone prefers to convert part of
the pyruvate pool into lactate is still unclear.
An impaired pyridine nucleotides shuttling into the mitochondria may be hy-
pothesized. Indeed, in this condition, pyruvate reduction into lactate would be used
as an alternative NADH recycling system, needed to enable the proceeding of the
glycolytic flux (as reported in figure 2.3 on page 23).
A combination of intrinsic cell characteristics and media composition has been
reported to influence lactate metabolism. Indeed, presented data show that medium
2 fosters lactate consumption in the subclone. Accordingly, subclone ∆ψm and O2
consumption are comparable to the control cells (Fig. 7.3). In the CD CHO medium,
instead, even the control cells accumulate higher amounts of lactate. Consequently,
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the mitochondrial membrane potential and oxygen consumption are reduced on day
7, when compared to the same cell line in medium 1 (Fig. 7.4).
Considering these data, the measurement of the mitochondrial membrane po-
tential, or the oxygen consumption rate, can be proposed as a marker of an im-
paired lactate metabolism in CHO cells. This could be of interest either in the clones
selection process, as already proposed by Hinterkörner et al. (Hinterkörner et al.,
2007), or in media optimization, to identify key metabolites which can boost oxida-
tive metabolism.
Three candidate components have been identified which are present at signifi-
cantly different concentrations in medium 1 and 2. Among these, alanine and copper
are able to impact both lactate and NH+4 metabolism (Fig. 7.6).
Alanine is normally used by the cells when other carbon sources are depleted,
as already discussed in section 6.2 on page 48. In medium 1, a higher alanine con-
sumption has been reported for the subclone after day 7, compared to the control
cells (Fig. 6.3 on page 50). Interestingly, medium 2 supplementation with alanine
increased the residual lactate concentration in the subclone culture (Fig.7.6E , cir-
cles versus triangles). The obtained result indicates that the subclones, even if it is
able to consume lactate, prefers to use alternative sources of energy, such as ala-
nine, when they are available. The observed increase in NH+4 concentration can also
be ascribed to alanine metabolism, either due to the alanine dehydrogenase activity,
which directly converts alanine to pyruvate with production of NH+4 and NADH, or to
the alanine transaminase enzyme. This enzyme catalyses the conversion of alanine
plus α-ketoglutarate to pyruvate and glutamate. The latter is then recycled back to
α-ketoglutarate via glutamate dehydrogenase with the release of NH+4 . Li et al. also
reported a link between lactate, alanine and ammonia metabolism (Li et al., 2012).
Indeed, they observed a phase of alanine consumption which occurred late in culture
after lactate depletion and caused a rise of ammonia level in the medium. Therefore,
lactate feeding was proposed as a strategy to prevent the use of alanine. In this work,
on the contrary, the opposite behaviour has been observed in medium 1. Indeed,
the subclone consumes first alanine, while lactate is slightly oxidised only at the end
of the culture. Therefore, the lactate feeding strategy, although interesting, can be
applied only to cell cultures that show a strong lactate consumption capacity, as our
control cell line, but not for those cells that behave like the subclone.
The copper effect, instead, is visible only on lactate metabolism. Indeed, a re-
duced copper concentration results in higher lactate amount at the end of the cul-
ture, compared to the standard medium 2 (Fig. 7.6E, squares versus triangles). The
role of copper on lactate metabolism has already been described in literature (Qian
et al., 2011; Luo et al., 2011) . Indeed, copper is a cofactor of the cytochrome c oxy-
dase complex, which is a component of the electron transport chain. Therefore, sup-
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plementing the cells with higher copper most probably boosts the oxidative capac-
ity of the mitochondria; thus increasing pyruvate, and consequently lactate, oxida-
tion. Nevertheless, a too high copper concentration can be toxic as well (Scheiber
and Dringen, 2011). Moreover, copper plays also an important role in the function of
the superoxide dismutase. This enzyme promotes the detoxification of superoxides,
which are normal by-products of the mitochondrial respiration. Superoxides, as the
other reactive oxygen species, can cause cell damages and death if they accumulate
beyond a certain extent (Brand, 2010).
However, when medium 1 was supplemented with higher copper concentration,
no impact on lactate metabolism in the subclone was observed (data not shown).
Therefore, copper seems to be important, but not sufficient, to control lactate accu-
mulation. This result is also in agreement with data reported by Luo et al. (Luo et al.,
2011)
Biotin, instead, does not impact lactate metabolism in our model, despite its role
as a cofactor of pyruvate carboxilase. PC catalyses pyruvate conversion into oxaloac-
etate and represents an important anaplerotic reaction for the TCA cycle. However,
its expression has been reported to be at very low levels in CHO cells (Fogolín et al.,
2004; Kim and Lee, 2007b), which may explain the absence of a significant effect of
biotin supplementation on lactate metabolism.
It is noteworthy that alanine and copper effects are stronger in the subclone than
in the control cells, thus showing that the cell line variable still plays a key role. There-
fore, both media composition and cell line characteristics should be taken into ac-
count when designing a strategy to optimize cell metabolism.
In conclusion, the reported data confirm our hypothesis that the mitochondrial
oxidative capacity plays a key role in the control of lactate metabolism. Moreover,
copper and alanine have been clearly identified as key components to take into con-
sideration when designing a medium for CHO cell culture.
8Gene expression analysis
8.1 Introduction
Omic approaches are gaining a strong interest as strategies to improve bioprocess
performances (Schaub et al., 2012). Metabolomic, in particular, is widely used to
identify limiting nutrients, which can be then added into the basal medium or sup-
plemented as feeds (Sellick et al., 2011; Ma et al., 2009). Furthermore, this approach
can also be used to identify possible flux constraints which can be overcome by over-
expressing a specific enzyme. For instance, Chong et. al reported a strong extracellu-
lar malate accumulation in bioreactor cultures of recombinant CHO cells, which they
hypothesized was linked to an enzymatic bottleneck at the mitochondrial malate de-
hydrogenase. Its overexpression, indeed, not only reduced malate secretion, but it
also boosted the oxidative metabolism and ATP production (Chong et al., 2010).
Other omic strategies include transcriptomic and proteomic assays. The com-
mon goal is to find markers, normally enzymes or transporters, which can be linked
to an optimal growth, productivity or metabolism (Carlage et al., 2009; Yee et al.,
2008a; Schaub et al., 2010). These approaches have also been proposed as tools to
acquire a better understanding of the lactate metabolic shift in CHO cell culture
(Pascoe et al., 2007). For instance, the analysis of hybridoma cells which under-
went the metabolic shift to lactate consumption showed a down-regulation of the
glycolytic enzymes. However, in this case the slowing down of the glycolytic flux was
most probably the result of the culture system change from fed-batch to continuous,
where the glucose concentration was maintained at a very low level (Korke et al.,
2004a).
In a recent paper, Mulukutla et al. highlighted the importance of the signaling
pathways in the control of lactate metabolism. In particular, they reported a down-
regulation of several AKT1-regulated genes during the lactate consumption phase.
AKT1 is a known stimulator of glucose uptake and metabolism, therefore the reduc-
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tion of its activity would results in a slowdown in glycolysis. Consequently, the cells
would start to consume lactate as an alternative source of energy, even in presence
of high glucose concentration. Although these interesting results shed light on new
candidates for the control of lactate metabolism, the factors that control AKT activity
and promote the metabolic change still need to be identified (Mulukutla et al., 2012).
In the previuos chapter, the mitochondrial oxidative capacity has been identified
as a key factor in the modulation of lactate metabolism in our model. To better in-
vestigate this phenomenon, the expression levels of specific genes was evaluated in
conditions of opposite lactate metabolism.
8.2 Gene targets selection
The gene expression assay was performed using a custom made Real-Time PCR ar-
ray with mouse primers and probes, since CHO-specific primers were not available
at the moment of the test. Indeed, the CHO-K1 genome has been published only re-
cently (Xu et al., 2011). Nevertheless, a high homology between the mouse and chi-
nese hamster genome has been reported (of around 92 %), which supports the cross-
hybridization between the two species (Kantardjieff et al., 2009; Yee et al., 2008b).
The targets selected for the array included 44 different genes, reported in table
8.1, and 3 controls.
Table 8.1: Selected targets for the gene expression array
Gene symbol Gene name
Glycolysis
Hk1 hexokinase 1
Hk2 hexokinase 2
Pfkl phosphofructokinase, liver
Pfkm phosphofructokinase, muscle
Pkm2 pyruvate kinase, muscle 2
Pklr pyruvate kinase, L R isoform
Anaplerotic reaction andmiscellaneous
Pck1 phosphoenolpyruvate carboxykinase 1, cytosolic
Pck2 phosphoenolpyruvate carboxykinase 2, mitochondrial
Pc pyruvate carboxylase
Pdha1 pyruvate dehydrogenase, E1-alpha polypeptide
Pdk2 pyruvate dehydrogenase kinase, isoenzyme 2
Ldha lactate dehydrogenase a
Acly ATP citrate lyase
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continuing form the previous page
Gene symbol Gene name
Me1 malic enzyme 1, NADP(+) dependent cytosolic
Me2 malic enzyme 2, NAD(+) dependent mitochondrial
Me3 malic enzyme 3, NADP(+) dependent mitochondrial
Mdh1 malate dehydrogenase 1, cytosolic
Got1 glutamate oxaloacetate transaminase, cytolsolic
Got2 glutamate oxaloacetate transaminase, mitochondrial
TCA cycle
Cs citrate synthase
Mdh2 malate dehydrogenase 2, mitochondrial
Sdha succinate dehydrogenase complex, subunit a
Respiratory chain components
Cox4ai1 cytochrome c oxidase, subunit IV, isoform 1
Uqcrc2a ubiquinol-cytochrome c reductase core protein II
Atp5b ATP synthase, H+ transporting mitochondrial F1 complex, beta subunit
Uncoupling proteins and controller of mitochondrial metabolism
Ucp2 uncoupling protein 2
Ucp3 uncoupling protein 3
Ppargc1a peroxisome proliferator-actived receptor γ, coactivator 1α
Slc16a1 monocarboxylic acid transporter-1
Mitochondrial transporters
Slc25a10 dicarboxylate ion carrier
Slc25a12 aralar, aspartate glutamate carrier 1
Slc25a19 mitochondrial thiamine pyrophosphate carrier
Slc25a20 carnitine-acylcarnitine translocase
Slc25a21 mitochondrial oxodicarboxylate carrier
Slc25a22 glutamate carrier 1
Slc25a31 adenine nucleotide translocator
Tomm20 translocase of the outer mitochondrial membrane 20
Timm8a translocase of the inner mitochondrial membrane 8a
Timm9 translocase of the inner mitochondrial membrane 9
Timm13 translocase of the inner mitochondrial membrane 13
Timm22 translocase of the inner mitochondrial membrane 22
Control genes
18s 18s ribosomal RNA
Gapdh Glyceraldehyde 3-phosphate dehydrogenase
Hprt1 Hypoxanthine-guanine phosphoribosyltransferase 1
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The criteria for the selection of the glycolysis related targets was based on their
known role as rate limiting enzymes. In particular, the hexokinase isoform 2 and the
muscle pyruvate kinase were of great interest since they have been associated to a
high glycolytic rate in tumour cells (Mathupala et al., 1997; Christofk et al., 2008).
The anaplerotic reactions group includes enzymes which promote pyruvate, or its
precursor phosphoenolpyruvate, oxidation into the TCA cycle (PCK, PC and PDH)
thus reducing its conversion to lactate (Kim and Lee, 2007b; Neermann and Wagner,
1996). Pyruvate dehydrogenase kinase, on the contrary, inhibits the activity of PDH
by phosphorilation, therefore blocking the oxidation of pyruvate.
The malic enzyme converts malic acid into pyruvate, diverting it from the TCA
cycle. Malate accumulation is often observed in cell culture, probably due to a bot-
tleneck in the Krebs cycle (Ma et al., 2009; Sidorenko et al., 2008). Therefore, ME1 was
of particular interest for the model presented in this work to better investigate the ini-
tial phase of lactate production. For the same reason, MDH II was also introduced in
the test. The ATP citrate lyase catalyse the formation of AcetilCoA from citrate in the
cytosol, thus providing the building block for lipid synthesis. MDH and GOT exist as
mitochondrial and cytosolic isoforms. They are relevant not only for intermediates
production but also as part of the malate-aspartate shuttle (Barron et al., 1998).
The uncoupling proteins are mitochondrial proton transportes which dissipate
the electrochemical gradients necessary for ATP production. While UCP1 is the only
one clearly identified as able to mediate the non shivering thermogenesis, the func-
tion of UCP2 and 3 is still under investigation (Azzu and Brand, 2010). Interestingly,
Pecqueur et al. reported that UCP2 knock out cells depend more on glycolysis for
their energy production (Pecqueur et al., 2008). Moreover, its expression is promoted
by glutamine at the translational level (Nübel et al., 2008). Therefore, it appeared to
be a good candidate for the control of lactate metabolic switch. UCP3, instead, has
been linked to the control of ROS production, but there also hypothesis that it could
work as a pyruvate uniporter (Criscuolo et al., 2006; Mozo et al., 2006).
The peroxisome proliferator-actived receptor γ coactivator 1α (PGC1α) is a major
coordinator of different mitochondrial processes such as biogenesis, fatty acid oxi-
dation and respiration. Interestingly, it is enriched in tissues with an high oxidative
activity and its expression is regulated by the cell energy demand in a complex man-
ner (Fernandez-Marcos and Auwerx, 2011; Ventura-Clapier et al., 2008). Interestingly,
lactate has been reported to increase the expression of PGC1α and the monocarboxy-
late transporter-1 (MCT1) in L6 cells (Hashimoto et al., 2007). MCT1, in particular,
mediates the transfer of pyruvate and lactate across the cell membrane.
Finally, the last group reported in table 8.1 includes the solute carriers family (slc),
which transports different metabolic intermediates across the mitochondrial mem-
brane. In more detail, Slc25a10 transports dicarboxylates such as malate and suc-
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cinate. Aralar1 promotes the exchange of glutamate with aspartate, and it is also
a component of the malate-aspartate shuttle (Rubi et al., 2004; Neupert and Her-
rmann, 2007). Slc25a19 translocates the thiamine pyrophosphate, which is the co-
factor of decarboxylase enzymes, such as PDH and α-ketoglutarate dehydrogenase.
The carnitine-acylcarnitine translocase promotes the transfers of fatty acids into the
mitochondria for oxidation. Lastly the group of translocases of the inner and outer
mitochondrial membrane allows the correct sorting and localization of the proteins
targeted to the mitochondria (Arco and Satrústegui, 2005; Rehling et al., 2003).
8.3 Gene expression array results
The described array was used to monitor gene expression in the subclone versus the
control cell line during the culture in medium 1. Samples were harvested on day
6, when the control cells probably start a metabolic reorganization for the shift to
lactate consumption; and on day 9, when the lactate profile is strongly different be-
tween the two cell lines. The real-time PCR data were analysed using the comparative
∆∆Ct method, with the lactate consuming condition considered as reference sample.
GAPDH was selected as endogenous control, since it showed the lowest variability
during the culture and between the two cell lines compared to the others (18S and
Hprt1). In table 8.2, only the sequences that gave rise to a reliable amplification sig-
nal are reported.
In order to confirm the observed results and to have a more general view, two
additional cell lines were included in the test. More precisely, the recombinant clone
G4, which was able to switch to lactate consumption as the control cell line, and the
recombinant clone C6, which instead had a lactate profile similar to the subclone
(Fig. 8.1 D)1. It should be noted, however, that clone G4 had a limited growth in this
culture condition, but still consumed glucose faster than clone C6 (Fig. 8.1 A and C).
Both recombinant clones were derived from a CHO-GS cell line, produced the same
protein and were kept under the standard culture conditions (batch culture in tube
spins with medium 1).
When a stringent fold change cut off of |FC≥ 2| was applied, only two genes, ar-
alar1 and timm8a, resulted to be significantly downregulated in the subclone on day
6 (p value <0.001, Student’s t-test from four independent tests). On day 9, only ar-
alar1 fitted the cut off requirement. Nevertheless, if a more relaxed cut off of |FC≥
1,5| was considered, timm8a down-regulation would be significant also on day 9 (p
value <0.005, Student’s t-test). According to this cut off, other genes would show a
significant change of expression on day 6. However, they were not considered fur-
ther, since on this time point the lactate profile was not strongly different between
1For control and subclone lactate profile refer to figure 6.2 on page 49
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Figure 8.1: Recombinant clone G4 (circles) and C6 (squares) growth and metabolic
profiles in medium 1. Mean ± standard deviations from two independent cultures.
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Table 8.2: Expression fold changes for the lactate producer cell line versus the lactate
consumer in medium 1. Values in bold fit the |FC≥ 2| cut off, while italics values fit
the |FC≥ 1,5| cut off.
subclone vs control clone C6 vs clone G4
Gene name
day 6 day 9 day 6 day 9
Hexokinase 2 (–) 1.40 (+) 1.46 (+) 1.12 (–) 1.14
Phosphofructokinase liver (–) 1.90 (+) 1.06 (+) 1.18 (–) 1.54
Phosphofructokinase muscle (+) 1.08 (+) 1.43
Pyruvate dehydrogenase a1 subunit (–) 1.35 (–)1.30
Pyruvate dehydrogenase kinase 2 (+) 1.34 (–) 1.01 (+) 1.21 (–)1.15
Citrate syntase (–) 1.01 (+) 1.17
Citrate lyase (–) 1.11 (+) 1.08 (+) 1.06 (–)1.75
Succinate dehydrogenase (–) 1.60 (+) 1.46 (–) 2.22 (–)1.15
Malate dehydrogenase 2 (–) 1.17 (+) 1.04 (–) 1.11 (–) 1.22
Malate dehydrogenase 1 (–) 1.23 (+) 1.27 (–) 1.16 (–) 1.12
Malic enzyme 1 (–) 1.69 (+) 1.10 (-) 1.11 (–) 1.23
Glutamate-oxaloacetate transaminase 2 (–) 1.45 (+) 1.09 (+) 1.14 (–) 1.37
Aralar1 (–) 2.77 (–) 2.08 (–) 3.23 (–) 2.44
Mitochondrial dicarboxylate carrier (–)1.80 (+) 1.05 (–) 4.35 (–) 1.53
Mitochondrial glutamate carrier (–) 1.07 (+) 1.16 (+) 1.23 (–) 1.72
Monocarboxylic acid transporter (–) 1.65 (+) 1.42 (–) 1.23 (–) 1.32
Timm 22 (–) 1.54 (–) 1.11 (–) 1.56
Timm 8a (–) 2.43 (–) 1.75 (–)1.40 (–) 1.72
Timm 13 (+) 1.02 (–) 1.04 (+) 1.02 (–) 1.19
upregulated sequences, (+); downregulated sequences (–)
76 8. GENE EXPRESSION ANALYSIS
the two cell lines.
Interestingly, the recombinant clone C6 showed also a significant reduction of
aralar1 expression on both days of test. Timm8a, instead, would be included only
on day 9, according to the |FC≥ 1,5| cut off. Succinate dehydrogenase and the mito-
chondrial dicarboxylate carrier were also down-regulated in the recombinant clone
C6, but only on day 6. Again, considering that the difference in the lactate profile was
evident on day 9, these two genes were not investigated further. Moreover, the ex-
pression of these two genes seemed to be more specific to the recombinant cell line,
since their levels were not significantly changed in the subclone. The same conclu-
sion applied to other genes that fitted the |FC≥ 1,5| cut off on day 9, but only in the
recombinant cell lines.
8.4 Aralar1 and timm8a expression in high lactate con-
ditions
8.4.1 Medium 2 versus medium 1
Aralar1 and timm8a expression was evaluated in other culture conditions or clones,
which showed differences of lactate metabolism, in order to verify if a general corre-
lation could be postulated.
As reported in figure 7.3 on page 61, the subclone became able to consume lac-
tate when cultivated in medium 2. This condition represented an interesting system
to investigate if aralar1 and timm8a expression correlated with the changed lactate
profile, suggesting a possible impact of media composition on these two genes.
For each cell line, the results obtained in medium 2 were compared with those
reported for medium 1. The test was performed only on day 8, which corresponded
to the growth peak in medium 2.
Table 8.3: Gene expression fold changes on day 8.
Medium 2 vs medium 1
Gene name
control subclone
aralar1 (+)1.20 (+)1.56
timm8a (+)1.00 (+)2.04
Aralar1 showed a significant increase of expression when the subclone was cul-
tivated in medium 2, if the |FC≥ 1,5| cut off was applied ( Table 8.3, p value < 0.001,
Student’s t-test on three independent assays). Timm8a was also upregulated but the
analysis was affected by a high variability, which weakened its significance (p value =
0.06).
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The two genes expression, instead, was not impacted by the change of media in
the control cell line. Accordingly, the lactate profile was the same in both medium 1
and 2.
8.4.2 CD CHO medium versus medium 1
In section 7.3 it has been reported that CD CHO medium is able to prevent the switch
to lactate consumption in the control cell line (Fig.7.4 on page 62).
Table 8.4: Gene expression fold changes on day 7.
CD CHO vs medium 1
Gene name
control subclone
aralar1 (–)6.90 (-)2.52
timm8a (–)2.70 (–)1.18
Therefore, aralar1 and timm8a expression was measured in CD CHO cultures of
both cell lines and was compared to the values obtained in medium 1. Samples were
harvested on day 7 of cultures, which corresponded to the growth peak in CD CHO.
Indeed, as shown in table 8.4, a strong decrease of both gene expression was de-
tected in the control cell line when cultivated in CD CHO medium (p value < 0,001,
Student’s t-test form two independent assays). Even the subclone showed a decrease
of gene expression in CD CHO medium compared to medium 1. However, this was
valid only for aralar1.
8.4.3 Fed-batch culture
Finally, aralar1 and timm8a expression was also evaluated in fed-batch cultures. The
recombinant cell line used for the test (referred next as recombinant clone A1) was
generated similarly to the G4 and C6 clones, but represented a different colony.
Table 8.5: Gene expression fold changes on day 10.
Gene name Feed 2 vs feed 1
aralar1 (–)1.92
timm8a (–)2.42
Cells were grown in CD CHO medium and supplemented with two different feed-
ing regimes (referred next as feed 1 and feed 2), which differently influenced the abil-
ity to shift to lactate consumption (Fig. 8.2 B). Samples were recovered on day 10 of
culture and the lactate consuming condition was taken as reference sample for the
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Figure 8.2: Recombinant clone A1 growth (A) and lactate profile (B) in CD CHO
medium. The culture medium was supplemented with feed 1 (circles) or feed 2
(squares) on different days during the growth. Mean ± standard deviations from du-
plicate cultures.
data analysis. It should be noted that although cells were no more in the exponen-
tial growth phase on the day of the test, both feeding conditions showed a similar
decrease in cell viability.
As reported in table 8.5, aralar1 and timm8a expression was downregulated when
the cells were supplemented with feed 2. Accordingly, this feeding regime induced a
higher lactate accumulation compared to feed 1.
In conclusion, the reported results indicated a correlation between a strong lac-
tate production and aralar1 and timm8a downregulation in the tested conditions.
8.5 Discussion
Gene array can be an informative tool to correlate specific genes expression with
the observed metabolic state and provide promising targets for host cell engineer-
ing (Wlaschin et al., 2006). For this reason, the expression of selected genes has been
evaluated in our culture model, and also in different cell lines or culture conditions
which showed opposite lactate profiles. The targets have been specifically chosen for
their possible relation with the mitochondrial oxidative activity and lactate produc-
tion.
From the gene expression analysis, two gene resulted to be down-regulated in
conditions of high lactate production: aralar12 and timm8a (Table 8.2). In particular
aralar1 shows a stronger down regulation which is maintained until the end of the
2The predicted CHO-K1 sequence for aralar1 became available during the writing of this
manuscript. The homology with the mouse cDNA was of 92 % (XM 003495954.1 and NM 172436.3)
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growing phase. More interestingly, the same result has been obtained not only for the
model cell lines, but also in two recombinant clones which also differ for their lactate
profile (clone G4 and C6). Moreover, it should be noted that the cut off selected for
the study (|FC≥ 2|) is considered as a rather stringent for gene expression comparison
in mammalian cell cultures. Indeed, it has been reported that only a small percentage
of genes show a more than two fold expression change in microarray analysis, even
when butyrate treated cells are compared to untreated (Wlaschin et al., 2006; Schaub
et al., 2010). A more relaxed cut off of (|FC≥ 1.5|) is indeed often used (Qian et al.,
2011; Yee et al., 2008a; Korke et al., 2004a). Therefore, it was also included in the
study.
Several culture conditions have been tested to further verify if a possible correla-
tion between the expression of these two genes and lactate metabolism could be con-
firmed. For instance, medium 2 and CD CHO represented an interesting condition
to validate our hypothesis, since they are able to differently influence the metabolic
shift. Interestingly, aralar1 and timm8a expression correlates with the observed lac-
tate profile in these media (Table 8.3 and 8.4). Finally, the same correlation has also
been observed in fed-batch cultures with two feeding strategies that differently im-
pact lactate metabolism (Table 8.5).
The reported results also indicate that unknown media components, or more
probably a more balanced metabolism, can influence the expression of these two
genes. However, even if tantalising, the mechanisms that control aralar1 and timm8a
expression in our culture conditions were not investigated further.
8.5.1 Aralar and timm8a role in cell metabolism
The connection between the identified genes and the cell lactate metabolism is well
described in the literature.
Aralar1 encodes for the mitochondrial aspartate-glutamate carrier (AGC), which
is a component of the malate-aspartate shuttle (MAS, Figure 8.3) and is localised
in the inner mitochondrial membrane. This system transfers reducing equivalents
from the cytosol to the mitochondria and its activity is necessary to regenerate the
cytosolic NAD+ pool required for the progression of glycolysis. Indeed, the cytoso-
lic reduction of oxaloacetate into malate releases NAD+. Malate is then transported,
in exchange for α-ketoglutarate, into the mitochondrial matrix where it is oxidised
back to oxaolacetate, with NADH production. NADH is then oxidised in the electron
transport chain to generate ATP. To complete the shuttle, oxaloacetate reacts with
glutamate to give aspartate and α-ketoglutarate. Aspartate is hence exported to the
cytosol in exchange for glutamate. Finally, the inverse transaminase reaction occurs
in the cytosol to give back oxaloacetate.
Another shuttle system exists: the glycerol-3-phosphate shuttle (GPS). Two iso-
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Figure 8.3: The malate-aspartate shuttle. cAAT and mAAT, cytosolic and mitochon-
drial aspartate aminotransferase; cMDH and mMDH, cytosolic and mitochondrial
malate dehydrogenase; LDH, lactate dehydrogenase; OAA, oxaloacetate; α-KG, α-
ketoglutarate. Modified from McKenna et al. (2006)
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forms of the enzyme glycerol-3-phosphate dehydrogenase (G3PDH) are involved in
the process. The cytosolic G3PDH converts dihydroxyacetone phosphate to glycerol-
3-phosphate realising NAD+. Afterwards, glycerol-3-phosphate is reconverted into
dihydroxyacetone phosphate by the mitochondrial G3PDH. This enzyme is localized
on the outer surface of the inner mitochondrial membrane and is FAD dependent
(Bender et al., 2006). Therefore, GPS has a lower energy yield compared to MAS.
Moreover, it has been reported that GPS activity is insufficient to compensate for an
impaired MAS functioning or in conditions of high cytosolic NADH levels, such as
during lactate consumption (Barron et al., 1998). In general, according to the liter-
ature analysis, MAS activity seems to be of greater importance than GPS, especially
when lactate is used as carbon source (Satrústegui et al., 2007). Therefore, our study
was focused more on the malate-aspartate shuttle.
The aspartate-glutamate carrier, specifically, promotes the aspartate efflux to the
cytosol, in exchange with glutamate plus a proton. As a consequence of its electro-
genic activity, AGC functioning is favoured in active mitochondria (Palmieri et al.,
2001). Two isoforms of this carrier have been identified: AGC1 (aralar1) and AGC2
(citrin), which belong to the calcium-binding mitochondrial carriers family. Aralar1
is expressed in most tissues, mainly pancreatic islets, muscle and brain; while citrin
is more enriched in the liver, where it is also involved in the urea cycle (Satrústegui
et al., 2007). Indeed, mutations of citrin have been associated to the type II citrulli-
naemia disease, which is characterized by ammonia build up in the blood (Kobayashi
et al., 1999).
AGC plays a crucial role in the functioning of the shuttle, since it promotes the
only irreversible step of the process (Satrústegui et al., 2007). Its activity is calcium
stimulated. Indeed, the amino-terminal extension harbours EF-hand Ca2+-binding
motifs, which face the inter-membrane space. In this way, the extramitochondrial
calcium level can regulate AGC activity (Palmieri et al., 2001; Lasorsa et al., 2003; Gel-
lerich et al., 2010).
MAS activity has been extensively studied in β-cells, where insulin secretion is
linked to the glycolytic flux, respiratory chain activity and the consequent rise of ATP
levels (Bender et al., 2006). Indeed, in these cells glycolysis is closely connected to the
mitochondrial metabolism, in order to fulfil the ATP requirement for insulin secre-
tion. Therefore, the malate aspartate shuttle plays a key role to support an efficient
transfer of reducing equivalents into the mitochondria. Moreover, LDH activity in
β-cells is quite low (Sekine et al., 1994), therefore the amount of NADH that is used
to reduce pyruvate into lactate is limited. It has also been shown that aralar1 overex-
pression in β-cells can elicit an increase of glucose oxidation to CO2, boost ATP pro-
duction and insulin secretion. More interestingly, lactate release was also reduced,
even if the total amount of consumed glucose was unchanged. This suggests that
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MAS activity modulates the fraction of pyruvate which is oxidised into the mitochon-
dria or reduced to lactate (Rubi et al., 2004). Conversely, AGC1 silencing resulted in
the opposite effects, at least on tumour-derived insulin secreting cells (Casimir et al.,
2009).
Another site of particular interest for aralar1 activity is represented by the brain
which shows peculiar characteristics in terms of lactate homoeostasis and shuttle ex-
pression. It has been reported that, after the glutamate stimulus, astrocytes engage
mostly in aerobic glycolysis and release lactate. The latter is then used by neurons
as energy source. This type of cell-cell lactate shuttle, known as the neuron-glia cou-
pling (Magistretti, 2006), has been reported also for other tissues (Brooks, 2009). In-
terestingly, aralar1 is highly enriched in neurons, while lower levels can be detected
in astrocytes (McKenna et al., 2006), thus confirming its crucial role in lactate oxida-
tion.
Figure 8.4: The mitochondrial membrane translocation system. (A) substrates of the
small Timm complex: MC, mitochondrial carrier and CaMC, calcium-binding mito-
chondrial carriers. (B)Translocation pathway for the MC proteins (1) and the CaMC
(2). IMS= intermembrane space, OM= outer membrane, IM= inner membrane. From
Arco and Satrústegui (2005)
The other identified gene, timm8a, is a component of the mitochondrial translo-
case system. This complex of proteins favours the import from the cytosol and cor-
rect localization of the mitochondrial proteins (Neupert and Herrmann, 2007). In
particular, timm8a, together with its partner timm13, act as chaperone-like proteins.
Their role is to facilitate the transport of proteins belonging to the family of calcium-
binding carriers, such as aralar1, across the inter-membrane space to the TIMM22
8.5. DISCUSSION 83
complex. The latter mediates the carrier insertion into the inner mitochondrial mem-
brane (Fig. 8.4). Timm8 mutations have been associated to the deafness/dystonia
syndrome. Decreased mitochondrial NADH levels were observed in lymphoblasts
derived from patients cultivated in presence of lactate. This was caused by the im-
paired AGC translocation, which did not allow a correct shuttling of the NADH pro-
duced during lactate oxidation (Roesch et al., 2004).
Interestingly, Korke et al. reported a 1.4 fold upregulation of timm13 in hybridoma
that underwent the metabolic shift to lactate consumption (Korke et al., 2004b). How-
ever, no great attention was paid to this gene and further investigation has not been
reported.
It is noteworthy that Timm8a expression levels vary among different tissues, with
a prominent enrichment in neurons and liver. Interestingly, its tissue distribution
correlates also with aralar1 and citrin expression, respectively (Roesch et al., 2004).
In conclusion, considering the gene expression data and the literature review it
was speculated that the higher lactate production, observed in some culture condi-
tions, could be linked to an impaired NADH shuttling into the mitochondria. In this
situation, LDH activity would be favoured in the direction of lactate production, as
alternative system to regenerate the cytosolic NAD pool.
Lastly, even though the mechanisms underlying the observed downregulations
are not clear yet, aralar1 and timm8a seem to be promising candidates for CHO cell
engineering to improve lactate metabolism.

9Aralar1 and timm8a effect on lactate
metabolism
9.1 Introduction
In this chapter, the potential impact of the two genes, aralar1 and timm8a, on lactate
metabolism was investigated. At first, an inhibitor of the malate-aspartate shuttle
was tested in the control cells to evaluate if the switch to lactate consumption was
affected. Afterwards, aralar1 and timm8a were overexpressed in both control cells
and subclone to assess their effect on lactate profile and cell growth.
9.2 Malate-aspartate shuttle inhibition
Aminooxyacetic acid (AOAA) is an inhibitor of the pyridoxal-dependent enzymes,
such as the aspartate aminotransferase that is a key enzyme of the malate-aspartate
shuttle (DaVanzoa et al., 1966). Therefore, even if not strictly specific, AOAA is often
used to study the effect of MAS inhibition on cell physiology (Kauppinen et al., 1987;
Barron et al., 1998; McKenna et al., 2006; Contreras and Satrústegui, 2009).
Interestingly, when control cells were treated with 0.25 mM of AOAA, the switch to
lactate consumption after day 5 was prevented and a further accumulation occurred
(Fig. 9.1 D). A slight lactate consumption was observed at the end of the culture, at
the time point when glucose was depleted. The obtained lactate profile was therefore
comparable to the one normally observed for the subclone. Treated cells showed also
a slower cell death and a slight increase of NH+4 production (Fig. 9.1 A and E). On
the other hand, glucose and glutamine profile were not impacted (Fig. 9.1 B and C).
The mitochondrial membrane potential was also measured and , as expected, treated
cells showed a significant decrease of ∆Ψm on day 7 (Fig. 9.1 F).
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Figure 9.1: Aminooxyacetic acid effect on lactate metabolism in control cells. Cells
were seeded at 0.2*106 cells/mL in medium 1 and treated with 0.25 mM of AOAA from
day 0 (circles). Not treated cells (squares). (A) growth, (B) glutamine, (C) glucose, (D)
lactate, and (E) NH+4 profiles. Mitochondrial membrane potential (F) was measured
on day 7 and values are expressed as a percentage of the non treated cells (*, p value
< 0.05, Student’s t-test ). Mean ± standard deviation from two independent cultures
with duplicates.
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Overall, AOAA modified control cells metabolism making it more similar to the
subclone one (see Fig. 6.2 on page 49). Therefore, these results supported the hy-
pothesis that an inefficient NADH shuttling might represent a constraint to lactate
oxidation.
9.3 Aralar1 and timm8a overexpression
9.3.1 Clones selection and characterization
Stable clones overexpressing aralar1 or timm8a were obtained using a vector carrying
the mouse ORF with a C-terminal GFP tag. The GFP signal was used to screen stable
clones by flow cytometry. Positive clones were also further selected for their capacity
to grow in suspension cultures without formation of cell aggregates.
Control cell line Subclone Limiting dilution 
Timm8a 
 transfection 
Aralar1 
 transfection 
Timm8a 
 transfection 
Aralar1 
 transfection 
c#T1 
 
c#T2 
 
c#T6 
c#A4 
 
c#A6 
 
sc#T2 
 
sc#T5 
 
sc#T6 
sc#A1 
 
sc#A4 
 
sc#A5 
Figure 9.2: Stable transfected clones nomenclature and original parental cell lines are
described for better clarity.
Finally, eleven clones were kept for further characterization: five were generated
from the control cell line transfection and overexpressed either timm8a-GFP (re-
ferred next as c#T1, c#T2 and c#T6) or aralar1-GFP (referred next as c#A4 and c#A6).
Six clones were derived from the subclone transfection: three timm8a-expressing
clones (referred next as sc#T2, sc#T5 and sc#T6) and three aralar-expressing clones
were selected (referred next as sc#a1, sc#A4 and sc#A5). For better clarity, cell lines
interrelations are summarized in figure 9.2.
GFP signal was monitored for 30 days to ensure the stability of expression (Fig.
9.3) and the correct subcellular localization was validated by co-staining with the
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mitochondrial-specific dye, Mitotracker red (Fig.9.4).
9.3.2 Clones growth and metabolic profile
Selected clones were cultivated in medium 1 to evaluate the transgenes impact on
growth and metabolism. Since high lactate production is often associated to fast
proliferation, as in cancer cells (Vazquez et al., 2010; Jones and Thompson, 2009),
we postulated that improving the cell metabolism could have a potential negative
impact on cell growth.
Conversely, as shown in figure 9.5 and 9.6 A, the growth of the control cell line-
derived clones was generally comparable to the untransfected control. Only c#T1
behaved differently with a maximum cell density around 5×106 cells/mL. Interest-
ingly, all clones maintained the switch to lactate consumption after day 5, which still
corresponded to the time point when residual glutamine was low in the medium (Fig.
9.5 and 9.6 C and D).
Clone c#A6, exceptionally, did not engage in net lactate consumption after day 5
and also showed a big variability of the measured lactate values. Moreover, this clone
was also characterized by a faster glucose consumption and cell growth, with the de-
cline phase starting earlier than the other clones. Therefore, it can be speculated that
this different behaviour could reflect the depletion of important substrates towards
the end of the culture, which resulted in a higher residual lactate concentration and
variability.
In conclusion, timm8a or aralar1 overexpression did not strongly modify the char-
acteristic phenotype of the control cell line.
The recombinant clones generated from subclone transfection showed a more
variable growth (Fig. 9.7 and 9.8 A). However, most of them reached a growth peak
of at least 8× 106 cells/mL, except for sc#T6. Glucose and glutamine profiles were
similar to the untrasfected subclone (Fig. 9.7 and 9.8 B and C, respectively). Remark-
ably, the recombinant clones switched to net lactate consumption after day 5 and
simultaneously used lactate and glucose as sources of energy (Fig. 9.7 and 9.8 D).
The metabolic shift again correlated with the cell culture phase when glutamine was
almost depleted. Therefore, the resulting metabolic behaviour was more similar to
the control cell line.
For better comparison, recombinant clones and parental cell lines IVC (integral
of viable cell density) was also calculated and reported in graph with the lactate con-
centration on day 11 (Fig. 9.9). The control cell-derived clones showed no difference
in the residual lactate level compared to the untrasfected cell line, except for c#A6
as already discussed. Moreover, no significant correlation between cell growth and
lactate profiles could be highlighted.
Even though lactate was slightly consumed at the end of the subclone culture, its
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c#T1         70% c#T2        60% c#T6        40% 
A 
c#A4          70% c#A6         15% 
sc#T2        70% sc#T5       90% sc#T6         40% 
sc#A1       45% sc#A4      80% sc#A5        40% 
C 
D 
B 
Figure 9.3: Clones stability was validated by monitoring the GFP expression for one
month. (A and B) control cell line-derived clones, (C and D) subclone-derived clones.
Green fluorescence intensity is reported for positive gated populations (indicated as
%). Black line, day 8; blue line, day 17; orange line, day 23; green line, day 30.
90 9. ARALAR1 AND TIMM8A EFFECT ON LACTATE METABOLISM
A B C 
D E F 
Figure 9.4: The correct mitochondrial localization of timm8a (A to C) an aralar1 (D to
F) was evaluated by using the specific mitochondrial-dye, Mitotracker red. (A and D)
GFP, (B and E) Mitotracker red and (C and F) merge of both signals.
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Figure 9.5: Control-derived timm8a overexpressing clones cultivated in medium 1.
Growth (A), glutamine (B), glucose (C) and lactate metabolism (D) of the clones
(c#T1, empty squares; c#T2, grey squares and c#T6, cross) and control cells (circles).
Mean ± standard deviation from three independent cultures.
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Figure 9.6: Control-derived aralar1 overexpressing clones cultivated in medium 1.
Growth (A), glutamine (B), glucose (C) and lactate metabolism (D) of the clones
(c#A4, empty triangles; c#A6, filled triangles) and control cells (circles). Mean± stan-
dard deviation from three independent cultures.
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Figure 9.7: Subclone-derived timm8a overexpressing clones. Growth (A), glutamine
(B), glucose (C) and lactate metabolism (D) of the clones (sc#T2, empty squares;
sc#T5, grey squares and sc#T6, cross) and the untransfected subclone (diamonds)
in medium 1. Mean ± standard deviation from three independent cultures.
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Figure 9.8: Subclone-derived aralar1 overexpressing clones. Growth (A), glutamine
(B), glucose (C) and lactate metabolism (D) of clones (sc#A1, empty triangles; sc#A4,
filled triangles and sc#A5, stars) and the untransfected subclone (diamonds) in
medium 1. Mean ± standard deviation from three independent cultures.
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Figure 9.9: Integral of viable cell density and residual lactate concentration of the
recombinant clones derived from the control cell line (A and B) and the subclone
(C and D) on day 11. The untrasfected cell lines are referred as ctr, for the control
cells, and sc for the subclone. Mean ± standard deviation from three independent
cultures.
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residual concentration was still higher than in the recombinant clones. In particular,
timm8a clones showed a reduction of lactate levels of around 60% , for sc#T2 and
#T6, and of 80%, for sc#T5, compared to the untransfected subclone. For the aralar
clones, the residual lactate concentration decreased of 30%, for sc#A1, and of 50% ,
for sc#A4 and A5 (Fig. 9.9 D). It should also be noted that a weak increase of lactate
levels occurred at the end of culture for clones sc#A1 and #A4, which also impacted
the reported differences.
Clones sc#T5 and sc#A4, in particular, showed a more evident lactate consump-
tion after day 5, compared to the other clones (Fig. 9.7 D and 9.8 D). Interestingly,
this two clones were the most homogeneous population with the highest % of pos-
itive cells (Fig.9.10). Therefore, a correlation between the level of aralar or timm8a
expression with the extent of lactate consumption could be hypothesized, even if the
number of tested clones was not high enough to have statical significance.
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Figure 9.10: GFP fluorescence signal in recombinant clones. The untrasfected cell
line is in grey in all graphs. (A) blue, c#T1; red, c#T2; green, c#T6. (B) blue, c#A4; red,
c#A6. (C) blue, sc#T2; red, sc#T5; green, sc#T6. (D) blue, sc#A1; red, sc#A4; green,
sc#A6. Green fluorescence intensity is reported on X-axis in logarithmic scale.
9.3.3 Mitochondrial metabolism in recombinant clones
The induction of the metabolic shift to lactate consumption in the subclone-derived
clones most probably resulted in an increased pyruvate oxidation in the TCA cycle,
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together with a more efficient NADH shuttling. In order to verify if the mitochon-
drial oxidative metabolism was indeed improved, the oxygen consumption rate was
measured in the recombinant clones.
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Figure 9.11: Oxygen consumption in control-derived clones (A) and in subclone-
based clones (B). Normalized values are reported as percentage of the untransfected
cell lines.The test was performed on day 8 of culture in medium 1. Mean± standard
deviations from two independent tests. *, p value < 0.05; **, p value < 0.005 Student’s
t-test.
As expected, all sc# clones showed a significant increase in oxygen consumption
compared to the untransfected subclone (Fig. 9.11 B). The only exception was sc#T5
which showed a more variable oxygen consumption. On the other hand, transgene
expression did not impact the O2 consumption in clones derived from the control cell
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line (Fig.9.11 A) and this correlated with the unchanged metabolic profile observed
in this group of recombinant clones.
The mitochondrial membrane potential of the recombinant clones was also eval-
uated. All clones showed a ∆Ψm value comparable or higher than the control cell
line, thus confirming a state of increased mitochondria activity. However, a high
variability was observed, which was most probably due to growth phase and viability
differences among clones, and to GFP interference. Therefore, these data have not
been included.
9.4 Discussion
Data reported in this chapter confirmed aralar1 and timm8a as potential targets to
improve CHO lactate metabolism in industrial cell culture.
The malate-aspartate shuttle role was investigated by both inhibiting and pro-
moting its activity. Indeed, MAS activity inhibition with aminooxyacetate prevented
the switch to lactate consumption in the control cell line. Interestingly, the lactate
over production persisted until glucose depletion. Afterwards a slight consumption
occurred, as already observed in the subclone. Glucose profile, instead, was not im-
pacted by the treatment. The resulting behaviour clearly indicates that the higher
lactate accumulation can be due to a less efficient MAS functioning, which is no more
able to handle the NADH produced during glycolysis. Therefore, a part of it needs
to be recycled by pyruvate reduction. After glucose depletion, the NADH generated
during lactate oxidation can instead be re-oxidised by the residual MAS activity.
Aralar and timm8a overexpression resulted in an improved lactate metabolism.
Indeed, the clones derived from subclone transfection became able to switch to lac-
tate consumption after day 5, and oxidised glucose and lactate simultaneously (Fig.
9.7 and 9.8). Glucose metabolism remained unchanged, thus indicating that lac-
tate consumption was not due to a slowing down of the glycolytic flux, but it was
promoted by a better NADH oxidation through the malate-aspartate shuttle. Inter-
estingly, aralar1 and timm8a overexpression did not modify the metabolism of the
control cell line, since the shift to lactate consumption was maintained ( Fig.9.5 and
9.6). Accordingly, the oxygen consumption increased in the subclone-derived clones,
while it remained mostly unchanged in the others (Fig.9.11).
No strong difference has been observed between timm8a and aralar1 clones, in-
dicating that both genes positively impacted cell metabolism. However, while the
improvement observed for the aralar1 clones can be ascribed only to MAS activ-
ity, timm8a expression can have a wider downstream impact. Indeed, substrates of
timm8/timm13 complex include the aspartate/glutamate carrier, but also timm23
and most probably the ATP-Mg/Pi carrier.
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The ATP-Mg/Pi carrier is also a calcium activated transporter, as aralar1, and its
activity is modulated by the cytosolic Ca2+ levels (Arco and Satrústegui, 2005). It
catalyses the reversible transport of ATP-Mg in exchange for phosphate, through the
mitochondrial membrane, thus controlling the adenine nucleotide content in the
mitochondria (Gellerich et al., 2010). However, its exact role and how it interacts
with the other adenine translocators are still elusive.
Timm23, instead, is a component of the mitochondrial translocation machinery
and mediates the correct sorting of protein both directed to the matrix and the inner
membrane (Rehling et al., 2003). Therefore, an impairment of timm8a functioning
can impact the correct sorting of multiple proteins, which are timm23 substrates.
As already discussed, the deafness/dystonia disease has been linked to a timm8a
mutation. Its symptoms, indeed, are hypothesized to be the result of the reduced
timm23 translocation, which ultimately impacts the cell oxidative capacity (Roesch
et al., 2002).
In conclusion, aralar1 and timm8a seem to be good candidates to develop a host
cell line with an improved lactate metabolism. Indeed, their overexpression can en-
sure a more balanced link between glycolysis and mitochondrial metabolism and
favour lactate consumption, by promoting an efficient NADH shuttling into the mi-
tochondria.
Conclusions & perspectives
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10.1 Conclusions
An optimal cell metabolism is of paramount importance in industrial process in or-
der to obtain a sustained growth and high productivity. However, in vitro metabolism
is often deregulated with a fast and inefficient nutrient oxidation and byproducts ac-
cumulation. Lactate, as a waste product, can be detrimental for its impact on pH
and osmolarity, consequently to base addition (Lao and Toth, 1997). Therefore, an
excessive accumulation of lactate must be avoided and efforts are still made to better
understand and control lactate metabolism in industrial cell culture (Neermann and
Wagner, 1996; Altamirano et al., 2000; Chong et al., 2010).
In this study, lactate metabolism in CHO cell culture has been analysed with
two different but complementary approaches. At first, different media and cell lines
were compared to evaluate their impact on the mitochondrial oxidative metabolism.
Then, the expression of selected genes was analysed to identify possible correlations
with the observed lactate profile.
Lactate is most often considered as the end product of glucose consumption and
its production is generally associated to the exponential growth phase (Mulukutla
et al., 2010). In this work, instead, it was showed that glutaminolysis also plays an im-
portant role. This metabolic pathway is characteristic of fast proliferating cells, since
it provides the NADPH used for lipid synthesis (DeBerardinis et al., 2007). In our
model glutamine was rapidly consumed during the first 5-6 days to fuel the TCA cy-
cle. This phase was accompanied by a high lactate production. Probably, malate ef-
flux out of mitochondria and its conversion to pyruvate contributed to the observed
lactate build up. Later in culture, glutamine depletion induced the control cells to use
lactate as an alternative source of energy to replenish the TCA cycle. This hypothe-
sis is further supported by the fact that glutamine feeding on day 5 resulted in an
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almost stoichiometric lactate increase in the control cells. The switch to lactate con-
sumption still occurred, when also the extra glutamine was depleted. Glucose was
still at high concentration in the medium on the day of the shift and was consumed
simultaneously to lactate.
The isolation of a subclone of the control cells, which instead accumulated higher
amount of lactate in a glucose-dependent way, allowed a more in depth investigation
of the metabolic shift. The impact of the cell line and media composition was also
evaluated. Low alanine and high copper concentrations were identified as important
factors to maintain the metabolic switch. The role of copper was also highlighted by
Genentech (Luo et al., 2011). Nevertheless, the cell line still represented an important
parameter which impacted the magnitude of alanine and copper effect.
The mitochondrial oxidative capacity was also evaluated by measuring the mi-
tochondrial membrane potential and the oxygen consumption. Both parameters
showed a significant reduction in the conditions of high lactate accumulation. Most
probably, pyruvate diversion to lactate production caused a decrease of the mito-
chondrial oxidative metabolism, which was not counteracted by the oxidation of al-
ternative nutrients. Hence, these results confirmed that mitochondria play a key role
in the control of lactate oxidation.
The gene expression assay was, therefore, mostly focused on the analysis of mi-
tochondrial metabolism and intermediates uptake. Among the 22 amplified genes,
two , aralar1 and timm8a, were down-regulated in conditions of strong lactate accu-
mulation. Aralar1 is a key component of the malate-aspartate shuttle (MAS), which
allows for the oxidation of the cytosolic NADH (Bender et al., 2006). During glycoly-
sis, two molecule of NADH are produced at each cycle and they need to be recycled
to maintain the glycolytic flux. This can occur either through the malate-aspartate
shuttle or by pyruvate reduction into lactate. Therefore, if MAS activity is impaired,
as in the case of low aralar1 expression, the LDH pathway would be fostered.
In this work, it has been shown that MAS inhibition with aminooxyacetate blocked
the metabolic switch in the control cells. Moreover, the resulting metabolic pheno-
type was highly similar to the subclone one.
Aralar1 overexpression, instead, promoted the switch to lactate consumption in
the subclone. On the other hand, the already efficient lactate metabolism of the con-
trol cells was not perturbed by the transgene expression.
The other gene, timm8a, is a component of the mitochondrial translocation ma-
chinery and promotes the correct sorting of the proteins targeted to the inner mem-
brane, such as aralar1 (Roesch et al., 2004). Its overexpression induced the same im-
provement of lactate metabolism as aralar1. However, since timm8a can impact the
localization of other mitochondrial proteins , its effect can not be univocally ascribed
to an improved MAS functioning. To better elucidate this point the mitochondrial
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fraction should be analysed to evaluate the enrichment of timm8a and timm23 sub-
strates. However, this was not performed since it was beyond the scope of this thesis.
To summarize the studied model, it was postulated that during the first phase
of culture, the malate-aspartate shuttle is able to handle the NADH produced dur-
ing glycolysis, and lactate is mainly the result of a truncated TCA cycle (Fig. 10.1
A). Pyruvate reduction into lactate also contributes to NAD regeneration. After glu-
tamine depletion, the metabolic switch can occur only if MAS activity is sufficient to
counteract the extra NADH production, resulting from lactate oxidation (Fig. 10.1 C).
Otherwise, a stronger lactate accumulation would occur (Fig. 10.1 B).
MAS functioning, ultimately, depends directly on aralar1 expression level and ,in-
directly, on timm8a translocation activity.
10.2 Perspectives
This study highlighted the importance of mitochondrial oxidative capacity in lactate
metabolism. Optimized media can boost the mitochondrial metabolism, resulting
in an improved lactate profile. However, intrinsic cell characteristics, such as aralar1
expression, can also have an impact. Therefore, the monitoring of oxygen consump-
tion could be proposed as a tool to select clones with an optimal metabolism, or for
nutrients screening to improve media composition. However, further optimization
is needed to fulfil the high throughput level required for an industrial application.
It should be noted that oxygen probes are normally present in all culture biore-
actors. Nevertheless, the generated data are often not regarded as indicators of the
mitochondrial oxidative state, while they could be highly informative, for instance,
to evaluate the impact of a feed on the mitochondrial metabolism.
Aralar1 and timm8a were identified as promising targets for the generation of a
host cell line with improved lactate metabolism. However, their impact on productiv-
ity still need to be evaluated. Nevertheless, it can be speculated that a more efficient
substrates consumption in the recombinant clones would provide more energy for
the production of the therapeutic protein.
Moreover, it would be of interest to evaluate an inducible system for the overex-
pression of aralar1. Indeed, the possibility to switch from fast lactate accumulation to
consumption could be advantageous to exploit the rapid cell proliferation often as-
sociated to the lactate production phase. Afterwards, the transgene activation would
promote the lactate switch from waste product to energy source. This flexible system
could also be useful in case of optimized media where lactate consumption is already
favoured.
In this work, an impact of medium composition on aralar1 and timm8a expres-
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Figure 10.1: Hypothesized glucose and glutamine metabolism in the studied model
cell line. (A) Initial lactate production phase is common to the control and subclone
cells. After glutamine depletion only control cells consume lactate due to the higher
MAS expression (C), while the subclone accumulates lactate as alternative reaction
to reoxidise NADH (B).
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sion has been highlighted. Further analysis are needed to identify the key compo-
nents and the signaling pathways that are involved, which could open new possibil-
ities for both media optimization and cell engineering. The CHO-K1 genome avail-
ability provides possibilities to more precisely study other candidate genes, such
as PGC1α, which was, indeed, included in the study but no reliable signal was ob-
tained (Xu et al., 2011). PGC1α, in particular, regulate mitochondrial biogenesis and
metabolism and its expression and activity are finely regulated (Fernandez-Marcos
and Auwerx, 2011; Cantó and Auwerx, 2012). Another interesting target could be the
uncoupling proteins, UCP2 and 3. Interestingly, UCP2 expression is influenced by
glutamine at the translational level and it is hypothesized that it could have a role in
the metabolism of this amino acid (Criscuolo et al., 2006). UCP3 also seems to be
involved in the control of mitochondrial metabolism in presence of glucose and, in
particular, an activity in promoting pyruvate efflux out of the mitochondria has been
postulated (García-Martinez et al., 2001; Mozo et al., 2006).
In conclusion, this thesis work has shown that the integration of metabolic analy-
sis and transcriptome profiling can reveal new interesting insights to elucidate mam-
malian cell behaviour in industrial cell cultures and can provide tools to control it.
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